meta_title (ID:91)

7

MYELOID PANEL, BONE MARROW

Method:

Microscopic observation.

Mounting:

Delivery period:3

Sample:

5 mL Hematological extension Tripotassium EDTA (2-8 ºC - Refrigerate)

Transport:

Use a slide carrier box.

Reference V.:

Mielograma:

Reported for each case

162

METHEMOGLOBIN, BLOOD

Method:

Molecular absorption Spectrometry.

Mounting:

Delivery period:3

Sample:

5 mL Total blood Heparin lithium (2-8 ºC - Refrigerate)

BLV:

End of workday (Methemoglobin Inducers) < 1.50 %
End of workday (Nitrobenzene) < 1.50 %

Reference V.:

Unexposed personnel < 1.00 %

Review:

21/11/2010

909

MIA (MELANOMA INHIBITORY ACTIVITY, SERUM

Method:

Enzyme-Linked Immunoassay.

Mounting:

Delivery period:32

Sample:

1 mL Serum (2-8 ºC - Refrigerate)

Reference V.:

< 12.00 ug/L * 1.0 = ng/mL

973

MEXILETINE, SERUM

Method:

High efficiency liquid chromatography.

Mounting:

Delivery period:8

Sample:

1 mL Serum (2-8 ºC - Refrigerate)
Alt. 1 mL Plasma Tripotassium EDTA (2-8 ºC - Refrigerate)

Therapeutic R.:

2.79 - 11.16 umol/L * 0.179211 = mg/L

1078

MYOGLOBIN, SERUM

Method:

Immunochemiluminiscence.

Mounting:

Delivery period:2

Sample:

1 mL Serum (2-8 ºC - Refrigerate)
Alt. 1 mL Plasma Tripotassium EDTA (2-8 ºC - Refrigerate)
Alt. 1 mL Plasma Heparin lithium (2-8 ºC - Refrigerate)

Reference V.:

< 6.27 nmol/L * 17.5439 = ng/mL

Review:

09/04/2013

1217

METHYL MALONIC ACID, SERUM

Method:

Gas Chromatography - Mass spectrometry.

Mounting:

Delivery period:13

Sample:

1 mL Serum (-8 ºC - Freeze)

Sample extraction:

Freeze specimen immediately.

Reference V.:

< 0.50 umol/L

Review:

17/01/2011

1272

MERCURY, BLOOD

Method:

Inductively coupled plasma mass spectrometry

Mounting:

Delivery period:6

Sample:

2 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Alt. 2 mL Total blood Heparin lithium (2-8 ºC - Refrigerate)
Alt. 2 mL Total blood Sodium heparin (2-8 ºC - Refrigerate)

Sample extraction:

Use metal-free container.

BLV:

End of work week (Elemental mercury and inorganic compounds) < 49.90 nmol/L * 0.200401 = ug/L

Reference V.:

Unexposed personnel < 49.90 nmol/L * 0.200401 = ug/L

Review:

20/04/2018

1273

MANGANESE, BLOOD

Method:

Inductively coupled plasma mass spectrometry

Mounting:

Delivery period:3

Sample:

1 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Alt. 1 mL Total blood Heparin lithium (2-8 ºC - Refrigerate)
Alt. 1 mL Total blood Sodium heparin (2-8 ºC - Refrigerate)

Sample extraction:

Use metal-free container.

Reference V.:

127.40 - 327.60 nmol/L * 0.054945 = ug/L

Review:

20/04/2018

1274

MANGANESE, SERUM

Method:

Inductively coupled plasma mass spectrometry

Mounting:

Delivery period:6

Sample:

1 mL Serum (2-8 ºC - Refrigerate)

Sample extraction:

Use metal-free container.

Reference V.:

< 56.42 nmol/L * 18.2 = ug/L

1285

MAGNESIUM, ERYTHROCYTES

Method:

Atomic absorption Spectrometry (Flame ifurnace).

Mounting:

Delivery period:3

Sample:

1 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Alt. 1 mL Total blood Heparin lithium (2-8 ºC - Refrigerate)
Alt. 1 mL Total blood Sodium heparin (2-8 ºC - Refrigerate)

Sample extraction:

Metal-free tubes (special for the determination of oligoelements) must be used.

Reference V.:

1.65 - 2.65 mmol/L * 2 = mEq/L

Review:

20/04/2018

1350

MOG NEURONAL ANTIBODIES, CSF and SERUM

Method:

Imunocitochemistry (Cell Based Assay).

Mounting:

Delivery period:21

Sample:

1 mL Cerebrospinal liquid (2-8 ºC - Refrigerate)
1 mL Serum (2-8 ºC - Refrigerate)

Reference V.:

Negative
Negative

1374

MYELIN ANTIBODIES, IgM, SERUM

Method:

Indirect Immunofluorescense.

Mounting:

Delivery period:10

Sample:

Alt. 1 mL Plasma Tripotassium EDTA (2-8 ºC - Refrigerate)
1 mL Serum (2-8 ºC - Refrigerate)

Interpretation:

Positive: >= to 1/5 Titulo

Negative:

< 1/5 Titulo

1504

MITOCHONDRIAL ANTIBODIES, SERUM

Method:

Indirect Immunofluorescense.

Mounting:

Delivery period:2

Sample:

1 mL Serum (2-8 ºC - Refrigerate)

Interpretation:

Positive: >= to 1/40 Titulo

Negative:

< 1/40 Titulo

Review:

26/06/2013

1538

MICROSOMAL (TPO) ANTIBODIES, SERUM

Method:

Immunochemiluminiscence.

Mounting:

Delivery period:1

Sample:

1 mL Serum (2-8 ºC - Refrigerate)
Alt. 1 mL Plasma Tripotassium EDTA (2-8 ºC - Refrigerate)

Interpretation:

Negative: < 60.00 UI/mL

Review:

09/04/2013

1645

MYCOBACTERIA (ANTIGEN A-60) ANTIBODIES, IgG, SERUM

Method:

Enzyme-Linked Immunoassay.

Mounting:

Delivery period:15

Sample:

1 mL Serum (2-8 ºC - Refrigerate)

Interpretation:

Indeterminate: 125.00 - 225.00 U/mL

Positive:

> 225.00 U/mL

Negative:

< 125.00 U/mL

Review:

20/04/2018

1646

MYCOBACTERIA (ANTIGEN A-60) ANTIBODIES, IgM, SERUM

Method:

Enzyme-Linked Immunoassay.

Mounting:

Delivery period:15

Sample:

1 mL Serum (2-8 ºC - Refrigerate)

Interpretation:

Indeterminate: 0.90 - 1.10 Indice

Positive:

> 1.10 Indice

Negative:

< 0.90 Indice

1733

MIELIN ASSOCIATED GLICOPROTEÍN (MAG) IgM ANTIBODIES, SERUM

Method:

Indirect Immunofluorescense.

Mounting:

Delivery period:10

Sample:

0.5 mL Serum (2-8 ºC - Refrigerate)

Interpretation:

Positive: >= to 1/5 Titulo

Negative:

< 1/5 Titulo

Review:

09/07/2013

1742

MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX, MUSCLE

Method:

Molecular absorption Spectrometry.

Mounting:

Delivery period:125

Sample:

0.1 g Muscle biopsy RPMI media (-8 ºC - Freeze)

Request form:

Clinical information required.
It´s necessary the birth date.
It´s necessary to contact previously with the laboratory for study programmation..

Reference V.:

25.00 - 54.00 nmol/minxmg Prt
0.27 - 0.45 U / U CS
0.50 - 0.93 U / U CS
0.16 - 0.31 U / U CS
103.00 - 207.00 nmol/minxmg Prt
0.15 - 0.27 U / UCS
0.52 - 1.04 U / U CS
27.00 - 48.00 nmol/minxmg Prt
0.07 - 0.18 U / U CS
18.00 - 37.00 nmol/minxmg Prt
78.00 - 186.00 nmol/minxmg Prt
127.00 - 222.00 nmol/minxmg Prt
37.00 - 82.00 nmol/minxmg Prt

1751

MUCOPOLYSACCHARIDES TIPIFICATION, URINE

Method:

Gas Chromatography - Mass spectrometry.

Mounting:

Delivery period:35

Sample:

25 mL Urine (-8 ºC - Freeze)

Request form:

Clinical information required.
It´s necessary the birth date.

Reference V.:

Reported for each case
Reported for each case
Reported for each case
Reported for each case
Reported for each case

1768

METHOXYACETIC ACID, URINE

Method:

Gas Chromatography - Mass spectrometry.

Mounting:

Delivery period:8

Sample:

10 mL End-of-day urine (2-8 ºC - Refrigerate)

1806

MYCOPLASMA PNEUMONIAE DNA, FLUIDS/EXUDATE

Method:

Real Time PCR.

Mounting:

Delivery period:11

Sample:

1 mL BAL (2-8 ºC - Refrigerate)
Alt. 1 mL Throat exudate (2-8 ºC - Refrigerate)

Sample extraction:

Do not send specimens with heparin because they inhibit the polymerase of PCR.

Reference V.:

Negative

Review:

01/04/2015

1834

METHYLETHYLKETONE, URINE

Method:

Gas chromatography - Detection with flame ionization

Mounting:

Delivery period:9

Sample:

5 mL End-of-day urine (2-8 ºC - Refrigerate)

BLV:

End of workday (Methylethylacetone) < 27.73 umol/L * 0.072114 = mg/L

Review:

21/11/2010

1842

MUCOPOLYSACCHARIDES (SCREENING), URINE

Method:

Turbidimetry.

Mounting:

Delivery period:21

Sample:

10 mL Urine (-8 ºC - Freeze)

Request form:

Clinical information required.

Sample extraction:

First voided morning urine specimen.

Reference V.:

Both 0 6 Months 7.10 - 18.00 mg/mmol crea
Both 1 2 Years 1.90 - 6.70 mg/mmol crea
Both 11 15 Years 0.50 - 3.10 mg/mmol crea
Both 16 18 Years 0.10 - 2.10 mg/mmol crea
Both 3 6 Years 1.70 - 5.40 mg/mmol crea
Both 7 10 Years 1.00 - 4.30 mg/mmol crea
Both 7 11 Months 3.30 - 7.30 mg/mmol crea

Review:

20/02/2014

1888

METHYL IMIDAZOLE ACETIC ACID, URINE

Method:

Gas Chromatography - Mass spectrometry.

Mounting:

Delivery period:24

Sample:

10 mL 24h urine (aliquot) Hydrochloric acid concentrated (37%). (2-8 ºC - Refrigerate)

Request form:

Diuresis required

Reference V.:

Excrecion:

< 4.50 mg/24h

Review:

05/03/2004

1944

METHADONE SCREENING, URINE

Method:

Gas Chromatography - Nitrogen-Phosphorus Detector.

Mounting:

Delivery period:5

Sample:

10 mL Urine (2-8 ºC - Refrigerate)

Discriminant V.:

0.30 ug/mL

Reference V.:

Negative

Review:

21/04/2018

1948

METHANOL, URINE

Method:

Gas chromatography - Detection with flame ionization

Mounting:

Delivery period:9

Sample:

5 mL End-of-day urine (2-8 ºC - Refrigerate)

BLV:

End of workday (Methanol) < 0.47 mmol/L * 32.0513 = mg/L

Review:

05/03/2004

1962

MHPG (3 METHOXY 4 HYDROXYPHENYLGLYCOL), URINE

Method:

High efficiency liquid chromatography - Electrochemical.

Mounting:

Delivery period:14

Sample:

10 mL 24h urine (aliquot) Hydrochloric acid concentrated (37%). (2-8 ºC - Refrigerate) pH=3

Request form:

Diuresis required

Reference V.:

4.90 - 19.00 umol/24h * 0.184162 = mg/24h

Review:

04/12/2009

1976

MAGNESIUM, URINE

Method:

Atomic absorption Spectrometry (Flame ifurnace).

Mounting:

Delivery period:3

Sample:

5 mL 24h urine (aliquot) Nitric Acid (2-8 ºC - Refrigerate) pH=1

Request form:

Diuresis required

Sample extraction:

No preservatives.
Centrifuge.
Use metal-free container.
In the case of oral anticoagulants, until prothrombin values are normal.

Reference V.:

3.00 - 5.00 mmol/24h * 24.3 = mg/24h

Review:

27/05/2005

1977

MANGANESE, URINE

Method:

Inductively coupled plasma mass spectrometry

Mounting:

Delivery period:3

Sample:

10 mL Urine (2-8 ºC - Refrigerate)

BEI:

Exposed personnel (Manganese) < 728.00 nmol/g creat. * 0.054945 = ug/g creat.

Reference V.:

Unexposed personnel < 54.60 nmol/g creat. * 0.054945 = ug/g creat.

Review:

23/11/2010

1986

MELANINA, URINE

Method:

Molecular absorption Spectrometry.

Mounting:

Delivery period:4

Sample:

1 mL Urine (2-8 ºC - Refrigerate)

Reference V.:

Negative

2030

MICROALBUMIN EXCRETION, URINE

Method:

Immunoturbidimetry.

Mounting:

Delivery period:1

Sample:

10 mL 24h urine (aliquot) (2-8 ºC - Refrigerate)

Reference V.:

Concentración:

< 20.00 mg/L * 0.001 = g/L

Excreción:

< 30.00 mg/24 h

Review:

09/04/2013

2117

MYELIN BASIC PROTEIN, CSF

Method:

Radioimmunoanalysis.

Mounting:

Delivery period:22

Sample:

1 mL Cerebrospinal liquid (-8 ºC - Freeze)

Reference V.:

<= to 4.00 ng/mL

Review:

21/04/2018

2150

MAGNESIUM, SEMINAL PLASMA

Method:

Atomic absorption Spectrometry (Flame ifurnace).

Mounting:

Delivery period:3

Sample:

1 mL Seminal plasma (2-8 ºC - Refrigerate)

Sample extraction:

Obtain semen specimen by masturbation.
Not valid if nocturnal emission has occurred.
Collect entire ejaculation in jar.

Reference V.:

> 2.88 mmol/L * 24.305 = ug/mL

Review:

27/05/2005

2211

MYCOPHENOLATE MOFETIL, PLASMA

Method:

High efficiency liquid chromatography.

Mounting:

Delivery period:10

Sample:

1 mL Plasma Tripotassium EDTA (-8 ºC - Freeze)
Alt. 1 mL Serum (-8 ºC - Freeze)

Sample extraction:

Freeze specimen immediately.

Therapeutic R.:

2.50 - 4.00 mg/L

Review:

04/07/2012

2386

MERCURY, URINE

Method:

Inductively coupled plasma mass spectrometry

Mounting:

Delivery period:6

Sample:

10 mL Urine Nitric Acid (2-8 ºC - Refrigerate) pH<2
Alt. 10 mL 24h urine (aliquot) Nitric Acid (2-8 ºC - Refrigerate) pH<2

Sample extraction:

Before workday.

For unexposed personnel:

24-hour urine specimen; diuresis required.

BLV:

Cociente:

Before workday. (Elemental mercury and inorganic compounds) < 149.70 nmol/g crea. * 0.200401 = ug/g crea.

Lethal C.:

Concentración:

> 4000.00 nmol/L * 0.200401 = ug/L

Reference V.:

Unexposed personnel < 99.80 nmol/L * 0.200401 = ug/L

Toxic C.:

> 750.00 nmol/L * 0.200401 = ug/L

Review:

30/05/2013

2411

METHYL HIPPURIC ACID, URINE

Method:

High efficiency liquid chromatography - Ultraviolet.

Mounting:

Delivery period:7

Sample:

10 mL End-of-day urine (2-8 ºC - Refrigerate)

BLV:

End of workday (Xylene) < 5263.16 umol/g.creat * 0.00019 = g/g.creat

Review:

26/05/2014

2479

MANTOUX INTRADERMAL REACTION 2 UT

Method:

Intradermoreaction.

Mounting:

Delivery period:1

Sample:

1 Sample/s Patient (2-8 ºC - Refrigerate)

Interpretation:

Positive: > 5.00 mm

Negative:

< 5.00 mm

BCG Positive:

> 14.00 mm

2483

MYOTONIC DYSTROPHY TYPE 1 (DM1) (DMPK GENE), BLOOD

Method:

PCR-Fragment length analysis+TP PCR.

Mounting:

Delivery period:35

Sample:

5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)

Request form:

Clinical information required.

Sample extraction:

Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.

Reference V.:

Reported for each case

Review:

17/05/2013

2489

MTHFR GENE (C677T MUTATION), BLOOD

Method:

Real Time PCR.

Mounting:

Delivery period:7

Sample:

3 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)

Request form:

Clinical information required.

Sample extraction:

Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.

Reference V.:

Reported for each case

Review:

21/04/2018

2509

MTHFR GENE (A1298C MUTATION), BLOOD

Method:

Real Time PCR.

Mounting:

Delivery period:7

Sample:

3 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)

Request form:

Clinical information required.

Sample extraction:

Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.

Reference V.:

Reported for each case

Review:

21/04/2018

2669

MYELOID PROGENITOR CELLS, BLOOD

Method:

In vitro culture.

Mounting:

Delivery period:31

Sample:

20 mL Total blood Heparin lithium (12-20 ºC - Ambient Temp.)

Request form:

Clinical information required.

Reference V.:

Resultado con EPO:

5.50 - 19.50 2x10Exp5 cel.

Resultado con FEC:

3.00 - 57.00 2x10Exp5 cel.

Resultado con MCL:

< 0.70 2x10Exp5 cel.

2803

MANDELIC / PHENYL GLIOXYLIC ACIDS, URINE

Method:

High efficiency liquid chromatography.

Mounting:

Delivery period:7

Sample:

10 mL End-of-day urine (2-8 ºC - Refrigerate)

Sample extraction:

End of workday.

BLV:

Mandelico+Fenilglioxilico:

End of work week (Ethylbenzene) < 700.00 mg/g.creat.
End of workday (Styrene) < 400.00 mg/g.creat.

Review:

26/09/2011

2821

MYCOBACTERIUM ATIPICAL DNA, BIOPSY

Method:

Real Time PCR.

Mounting:

Delivery period:25

Sample:

1 piece/s Biopsy RPMI media (2-8 ºC - Refrigerate)

Request form:

Clinical information required.

Reference V.:

Negative

Review:

11/03/2015

2831

MANDELIC / PHENYL GLIOXYLIC ACIDS, URINE INICIO

Method:

High efficiency liquid chromatography.

Mounting:

Delivery period:9

Sample:

10 mL Urine (2-8 ºC - Refrigerate)

Reference V.:

Not available

Review:

02/08/2011

2986

MOLYBDENUM, SERUM

Method:

Inductively coupled plasma mass spectrometry

Mounting:

Delivery period:3

Sample:

1 mL Serum (2-8 ºC - Refrigerate)

Sample extraction:

Metal-free tubes (special for the determination of oligoelements) must be used.

Reference V.:

1.04 - 32.31 nmol/L * 0.09594 = ug/L

Review:

12/10/2010

5033

MAMMARY CYTOLOGY

Method:

Papanicolaou smear / Microscopic observation.

Mounting:

Delivery period:5

Sample:

1 mL Mammary secretion (12-20 ºC - Ambient Temp.)

Sample extraction:

Fixation with Cytospray.

R.Values:

Reported for each case.

Review:

30/05/2008

5279

MICROPHOTOGRAPHY, BIOPSY

Method:

Photomicrograph.

Mounting:

Delivery period:14

Sample:

1 piece/s Biopsy Formaldehyde buffer (10%) (12-20 ºC - Ambient Temp.)

Reference V.:

Reported for each case

6084

MAGNESIUM, DRINKING WATER

Method:

Inductively coupled plasma mass spectrometry

Mounting:

Delivery period:10

Sample:

50 mL Water (Recipient, plastic) (pH<2 Nitric Acid)

Parametric V.:

Not established.

6108

MONOCHLORAMINE, DIALYSATE

Method:

Molecular absorption Spectrometry.

Mounting:

Delivery period:2

Sample:

200 mL Dialysis water (Recipient, plastic)

UNE 111-301-90:

< 0.10 mg NH2Cl/L

Review:

09/05/2008

6115

MAGNESIUM, DIALYSATE

Method:

Inductively coupled plasma mass spectrometry

Mounting:

Delivery period:3

Sample:

50 mL Water (Recipient, plastic) (pH<2 Nitric Acid)

UNE 111-301-90:

< 4.00 mg/L

Review:

22/04/2018

6206

MERCURY, DIALYSATE

Method:

Inductively coupled plasma mass spectrometry

Mounting:

Delivery period:3

Sample:

50 mL Dialysis water (Recipient, plastic) (pH<2 Nitric Acid)

UNE 111-301-90:

< 0.0002 mg/L

Review:

22/04/2018

6213

MANGANESE, DIALYSIS WATER

Method:

Inductively coupled plasma mass spectrometry

Mounting:

Delivery period:5

Sample:

50 mL Water (Recipient, plastic) (pH<2 Nitric Acid)

Ph. Eur. (1997):

< 0.10 mg/l

Review:

10/06/2009

6216

MANGANESE, DRINKING WATER

Method:

Inductively coupled plasma mass spectrometry

Mounting:

Delivery period:5

Sample:

50 mL Water (Recipient, plastic) (pH<2 Nitric Acid)

RD 140/2003:

< 50.00 ug/L

6222

MERCURY, DRINKING WATER

Method:

Inductively coupled plasma mass spectrometry

Mounting:

Delivery period:5

Sample:

50 mL Water (Recipient, plastic) (pH<2 Nitric Acid)

RD 140/2003:

< 1.00 ug/L

6305

MICROCYSTINE, DRINKING WATER

Method:

High efficiency liquid chromatography - Mass spectrometry.

Mounting:

Delivery period:10

Sample:

1000 mL Water (Recipient, plastic)

RD 140/2003:

< 1.00 ug/L

6311

MATERIAL IN SUSPENSION, WASTE WATER

Method:

Gravimetry

Mounting:

Delivery period:6

Sample:

200 mL Water (Recipient, plastic)

DC 130/2003:

< 750.00 mg/L

RD 849/1986:

Type I spill.: 150.01 - 300.00 mg/L

Type II spill.:

80.01 - 150.00 mg/L

Type III spill.:

<= to 80.00 mg/L

Review:

09/05/2008

6320

MOLYBDENUM, WATER

Method:

Inductively coupled plasma mass spectrometry

Mounting:

Delivery period:5

Sample:

50 mL Water (Recipient, plastic) (pH<1 Hydrochloric Ac.)

Parametric V.:

Not established.

6674

MONOCHLORAMINE, WATER

Method:

Molecular absorption Spectrometry.

Mounting:

Delivery period:1

Sample:

100 mL Dialysis water (Recipient, plastic)

Parametric V.:

Not established.

6675

MERCURY, WATER

Method:

Inductively coupled plasma mass spectrometry

Mounting:

Delivery period:5

Sample:

50 mL Water (Recipient, plastic) (pH<2 Nitric Acid)

Parametric V.:

Not established.

6676

MERCURY, WASTE WATER

Method:

Inductively coupled plasma mass spectrometry

Mounting:

Delivery period:5

Sample:

50 mL Water (Recipient, plastic) (pH<2 Nitric Acid)

DC 130/2003:

< 0.10 mg/L

RD 849/1986:

Type I spill.: 0.06 - 0.10 mg/L

Type III spill.:

<= to 0.05 mg/L

6679

MANGANESE, WASTE WATER

Method:

Inductively coupled plasma mass spectrometry

Mounting:

Delivery period:5

Sample:

50 mL Water (Recipient, plastic) (pH<2 Nitric Acid)

DC 130/2003:

< 2.00 mg/L

RD 849/1986:

Type II spill.: 2.01 - 3.00 mg/L

Type I spill.:

3.01 - 10.00 mg/L

Type III spill.:

<= to 2.00 mg/L

6750

MAGNESIUM, SWIMMING POOL WATER

Method:

Inductively coupled plasma mass spectrometry

Mounting:

Delivery period:5

Sample:

50 mL Water (Recipient, plastic) (pH<2 Nitric Acid)

Parametric V.:

Not established.

6751

MANGANESE, SWIMMING POOL WATER

Method:

Inductively coupled plasma mass spectrometry

Mounting:

Delivery period:5

Sample:

50 mL Water (Recipient, plastic) (pH<2 Nitric Acid)

Parametric V.:

Not established.

6752

MERCURY, SWIMMING POOL WATER

Method:

Inductively coupled plasma mass spectrometry

Mounting:

Delivery period:5

Sample:

50 mL Water (Recipient, plastic) (pH<2 Nitric Acid)

Parametric V.:

Not established.

6759

MOLYBDENUM, WATER

Method:

Inductively coupled plasma mass spectrometry

Mounting:

Delivery period:5

Sample:

50 mL Water (Recipient, plastic) (pH<1 Hydrochloric Ac.)

Parametric V.:

Not established.

6762

MOLYBDENUM, DIALYSATE

Method:

Inductively coupled plasma mass spectrometry

Mounting:

Delivery period:5

Sample:

50 mL Dialysis water (Recipient, plastic) (pH<1 Hydrochloric Ac.)

Parametric V.:

Not established.

6766

MOLYBDENUM, DRINKING WATER

Method:

Inductively coupled plasma mass spectrometry

Mounting:

Delivery period:5

Sample:

50 mL Water (Recipient, plastic) (pH<1 Hydrochloric Ac.)

Parametric V.:

Not established.

6771

MANGANESE, WATER

Method:

Inductively coupled plasma mass spectrometry

Mounting:

Delivery period:5

Sample:

50 mL Water (Recipient, plastic) (pH<2 Nitric Acid)

Parametric V.:

Not established.

6774

MAGNESIUM, WASTE WATER

Method:

Inductively coupled plasma mass spectrometry

Mounting:

Delivery period:5

Sample:

50 mL Water (Recipient, plastic) (pH<2 Nitric Acid)

Parametric V.:

Not established.

6775

MOLYBDENUM, WASTE WATER

Method:

Inductively coupled plasma mass spectrometry

Mounting:

Delivery period:5

Sample:

50 mL Water (Recipient, plastic) (pH<1 Hydrochloric Ac.)

Parametric V.:

Not established.

6803

MATERIAL IN SUSPENSION, WATER

Method:

Gravimetry

Mounting:

Delivery period:6

Sample:

200 mL Water (Recipient, plastic)

Reference V.:

Not established.

Review:

27/06/2009

6817

MAGNESIUM, WATER

Method:

Inductively coupled plasma mass spectrometry

Mounting:

Delivery period:5

Sample:

50 mL Water (Recipient, plastic) ( Nitric Acid)

Parametric V.:

Not established.

7023

MYCOPLASMA UROGENITAL, SERUM

Method:

Metabolism inhibition.

Mounting:

Delivery period:5

Sample:

1 mL Serum (2-8 ºC - Refrigerate)

Interpretation:

Ureaplasma Ureolitico:

Positive: >= to 1/2 Titulo

Negative:

< 1/2 Titulo

Mycoplasma Hominis:

Positive: >= to 1/2 Titulo

Negative:

< 1/2 Titulo

7024

MYCOPLASMA UROGENITAL, CULTURE

Method:

Culture broth selective for a panel of specific tests

Mounting:

Delivery period:2

Sample:

1 Smear Urethral exudate MT (Amies or Stuart) (12-20 ºC - Ambient Temp.)
1 Smear Vaginal exudate MT (Amies or Stuart) (12-20 ºC - Ambient Temp.)
25 mL Urine (12-20 ºC - Ambient Temp.)
1 mL Semen (12-20 ºC - Ambient Temp.)

Sample extraction:

See general instructions.
Only urine from male subjects can be used to culture urogenital mycoplasms.

Reference V.:

Reported for each case

Review:

01/04/2005

7097

MYCOBACTERIUM STUDY (LIQUID MEDIUM), CULTURE

Method:

Liquid culture. Identification by PCR.

Mounting:

Delivery period:45

Sample:

1 mL Pleural fluid (2-8 ºC - Refrigerate)
Alt. 1 mL Sputum/phlegm (2-8 ºC - Refrigerate)

Reference V.:

Reported for each case

Review:

02/03/2015

7390

MICROBIOLOGICAL CONTROL

Method:

Bacteriologic culture in specific media.

Mounting:

Delivery period:5

Sample:

1 mL Pharmaceutical suspension (2-8 ºC - Refrigerate)

Reference V.:

Reported for each case

7412

MYCOBACTERIUM SPP. SPUTUM

Method:

Liquid culture. Identification by PCR.

Mounting:

Delivery period:45

Sample:

1 mL Sputum/phlegm (2-8 ºC - Refrigerate)

Reference V.:

Reported for each case

7493

MRSA INVESTIGATION

Method:

Bacteriologic culture in specific media.

Mounting:

Delivery period:3

Sample:

1 Sample/s Microbiology specimen (2-8 ºC - Refrigerate)

Reference V.:

Cultivo MRSA:

Reported for each case

7525

MYCOBACTERIUM SPP., BIOPSY

Method:

Bacteriologic culture in specific media.

Mounting:

Delivery period:45

Sample:

1 Sample/s Biopsy (2-8 ºC - Refrigerate)

Reference V.:

Cultivo micobact. Biopsia:

Not available

Tinción Auramina Biopsia:

Not available

Tinción Ziehl Neelsen Biopsia:

Not available

7526

MYCOBACTERIUM SPP., PLEURAL BIOPSY

Method:

Bacteriologic culture in specific media.

Mounting:

Delivery period:45

Sample:

1 Sample/s Biopsy (2-8 ºC - Refrigerate)

Reference V.:

Cultivo micobact. Biopsia Pleural:

Not available

Tinción Auramina Biopsia Pleural:

Not available

7527

MYCOBACTERIUM SPP., TELESCOPING CATHETER

Method:

Bacteriologic culture in specific media.

Mounting:

Delivery period:45

Sample:

1 Smear Catheter (2-8 ºC - Refrigerate)

Reference V.:

Cultivo micobact. Catéter Telescopado:

Not available

Tinción Auramina Catéter Telescopado:

Not available

Tinción Ziehl Neelsen Catéter Telescopado:

Not available

7528

MYCOBACTERIUM SPP., STOOL

Method:

Bacteriologic culture in specific media.

Mounting:

Delivery period:45

Sample:

1 Sample/s Faeces (2-8 ºC - Refrigerate)

Reference V.:

Not available

Tinción Auramina Heces:

Not available

Tinción Ziehl Neelsen Heces:

Not available

7529

MYCOBACTERIUM SPP., LYMPHATIC NODE

Method:

Bacteriologic culture in specific media.

Mounting:

Delivery period:45

Sample:

1 Sample/s Lymph Node (2-8 ºC - Refrigerate)

Reference V.:

Cultivo micobact. Ganglio Linfático:

Not available

Tinción Auramina Ganglio Linfático:

Not available

Tinción Ziehl Neelsen Ganglio Linfático:

Not available

7530

MYCOBACTERIUM SPP., BLOOD CULTURE

Method:

Bacteriologic culture in specific media.

Mounting:

Delivery period:45

Sample:

1 Sample/s Total blood (2-8 ºC - Refrigerate)

Reference V.:

Cultivo micobact. Hemocultivo:

Not available

Tinción Auramina Hemocultivo:

Not available

Tinción Ziehl Neelsen Hemocultivo:

Not available

7531

MYCOBACTERIUM SPP., LCR

Method:

Bacteriologic culture in specific media.

Mounting:

Delivery period:45

Sample:

1 Sample/s Cerebrospinal liquid (2-8 ºC - Refrigerate)

Reference V.:

Cultivo micobact. (medio líquido) LCR:

Not available

Tinción Auramina LCR:

Not available

Tinción Ziehl Neelsen LCR:

Not available

7532

MYCOBACTERIUM SPP., ARTICULAR LIQUID

Method:

Bacteriologic culture in specific media.

Mounting:

Delivery period:45

Sample:

1 Sample/s Articular liquid (2-8 ºC - Refrigerate)

Reference V.:

Cultivo micobact. Líquido Articular:

Not available

Tinción Auramina Líquido Articular:

Not available

Tinción Ziehl Neelsen Líquido Articular:

Not available

7533

MYCOBACTERIUM SPP., ASCITIC LIQUID

Method:

Bacteriologic culture in specific media.

Mounting:

Delivery period:45

Sample:

1 Sample/s Ascites fluid (2-8 ºC - Refrigerate)

Reference V.:

Cultivo micobact. Líquido Ascítico:

Not available

Tinción Auramina Líquido Ascítico:

Not available

Tinción Ziehl Neelsen Líquido Ascítico:

Not available

7534

MYCOBACTERIUM SPP., PLEURAL LIQUID

Method:

Bacteriologic culture in specific media.

Mounting:

Delivery period:45

Sample:

1 mL Pleural fluid (2-8 ºC - Refrigerate)

Reference V.:

Cultivo micobact. Líquido Pleural:

Not available

Tinción Auramina Líquido Pleural:

Not available

Tinción Ziehl Neelsen Líquido Pleural:

Not available

7535

MYCOBACTERIUM SPP., BONE MARROW

Method:

Bacteriologic culture in specific media.

Mounting:

Delivery period:45

Sample:

1 Sample/s Bone marrow (2-8 ºC - Refrigerate)

Reference V.:

Cultivo micobact. Médula Ósea:

Not available

Tinción Auramina Médula Ósea:

Not available

Tinción Ziehl Neelsen Médula Ósea:

Not available

7536

MYCOBACTERIUM SPP., URINE

Method:

Bacteriologic culture in specific media.

Mounting:

Delivery period:45

Sample:

1 Sample/s Urine (2-8 ºC - Refrigerate)

Reference V.:

Cultivo micobact. Orina:

Not available

Tinción Auramina Orina:

Not available

Tinción Ziehl Neelsen Orina:

Not available

7537

MYCOBACTERIUM SPP., BRONCHOALVEOLAR LAVAGE

Method:

Bacteriologic culture in specific media.

Mounting:

Delivery period:45

Sample:

1 Smear BAL (2-8 ºC - Refrigerate)

Reference V.:

Cultivo micobact. Lavado Broncoalveolar:

Not available

Tinción Auramina Lavado Broncoalveolar:

Not available

Tinción Ziehl Neelsen Lavado Broncoalveolar:

Not available

7538

MYCOBACTERIUM SPP., SEMEN

Method:

Bacteriologic culture in specific media.

Mounting:

Delivery period:45

Sample:

1 Sample/s Semen (2-8 ºC - Refrigerate)

Reference V.:

Cultivo micobact. Semen:

Not available

Tinción Auramina Semen:

Not available

Tinción Ziehl Neelsen Semen:

Not available

7541

MYCOBACTERIUM SPP., ABSCESS

Method:

Bacteriologic culture in specific media.

Mounting:

Delivery period:45

Sample:

1 Sample/s SS (2-8 ºC - Refrigerate)

Reference V.:

Cultivo micobact. Absceso:

Not available

Tinción Auramina Absceso:

Not available

Tinción Ziehl Neelsen Absceso:

Not available

7600

MICROBIOLOGICAL CONTROL OF SURFACE, SURFACE

Method:

Bacteriologic culture in specific media.

Mounting:

Delivery period:13

Sample extraction:

See general instructions.

Request form:

Extraction date is required.

Sample extraction:

- Insert the cotton swab into the thinner flask and break the stick so that only the swab remains in the bottle.
- Wipe the second dry cotton swab in the same area selected with the first swab.
- Insert the second swab in the flask from the same way as before.

Transport:

The plates, once collected, will be sealed around with "Parafilm" to avoid the ball caps and possible accidental contamination, and must be transported refrigerated (2-4 º C) and protected from light. Similarly the swabs were sent. In addition, they shall be entered in the date and time of sampling.

Request form:

The type of specimen sent is required.

Sample extraction:

Prior sampling considerations
-------------------------------------------
In the environment and in the hands of technicians responsible for sampling, saprophytic microorganisms are present and that may lead to a misinterpretation of cultures due to improper handling of instruments. Hence the importance of using maximum measures of asepsis as well as an established order for sampling, avoiding as much as possible, the accidental contamination of the plates and mistakes in labeling the place where the sample has been obtained.

For all this, it is important to consider the following steps:

- Hand washing and use of sterile gloves.
- Form for data collection; label the plates with the appropriate culture medium and following the pre-established.
- After each sample, seal the used material for the sampling to avoid contamination in situ.

Sampling
---------------------------

The samples shall be implemented before the start of the surgical activity and upon completion of the hygiene of the area to study, with the least possible number of people present, without opening doors or moving any object while performing the sampling.

The culture media to be used will depend on the sample surface:

in accessible areas are pressing contact plates placed on the surface and hold still, and as evenly as possible during the contact.

In cases of irregular surfaces or difficult access to the contact plates, sterile cotton swabs must be used, and proceed as follows:

- Moisten the cotton swab with liquid transport media.
- Rub cotton swab doing lines together and side to side of the turunda.
- Insert the swab into the diluent's flask and break the stick so that only the swab remains in the bottle.
- Wipe the same area selected with the second swab dry.
- Insert the swab into the same flask and break the stick so that only the swab remains in the bottle.

In cases of flat or regular surfaces proceed the following way:

- Select an area of 100cm² for sampling with the assistance of a template.
- Humidify the cotton swab with the liquid media transport.
- Pressure the template firmly and moving it horizontally and then side to side.

R.Values:

For this reason the choice of the culture medium will also be conditioned and will be studied for each particular case.

Quantitative interpretation of data varies depending on the studied surface. But generally, for bacteria recounts:

a very clean environment would be less than 25UFC/cm ², and an acceptable environment would be less than 50 CFU / cm ².
Results Interpretation
-------------------------------------------

From the sample can be obtained quantitative data, the number of microorganisms present in a specific surface area (for smooth surfaces or flat:

UFC / cm ², for uneven surfaces: UFC / area sampled). And qualitative data, being the different species of microorganisms that have been collected in the study sample.

The detection limits of microorganisms and the type of pathogen to study, go on the basis of epidemiological data and / or health on the pollutants expected to be encountered in an environment (surfaces in an operating room in a specific location, etc.) But in most cases is not possible prior identification of the microorganism, so it is not ruling out the simultaneous use of both systems (contact plate and swab) to ensure a complete collection of all possible microorganisms.

8044

MULTIPLE ENDOCRINE NEOPLASIA TYPE 2A (RET GENE: EXONS 10 and 11), BLOOD

Method:

PCR-Sequencing.

Mounting:

Delivery period:35

Sample:

5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)

Request form:

Clinical information required.

Sample extraction:

Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.

Reference V.:

Reported for each case

8072

MULTIPLE ENDOCRINE NEOPLASIA TYPE 1 (MEN1 GENE: NGS), BLOOD

Method:

Next Generation Sequencing (NGS).

Mounting:

Delivery period:45

Sample:

10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)

Request form:

Clinical information required.

Sample extraction:

Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.

Reference V.:

Reported for each case

Review:

17/05/2013

8082

MIOSITIS PROFILE (IMMUNOBLOT), SERUM

Method:

Immunoblot.

Mounting:

Delivery period:10

Sample:

1 mL Serum (2-8 ºC - Refrigerate)

Review:

23/04/2018

8099

MYCOBACTERIUM ATIPICAL DNA, BIOLOGIC FLUID/SPUTUM

Method:

Polymerase chain reaction.

Mounting:

Delivery period:21

Sample:

1 mL Pleural fluid (2-8 ºC - Refrigerate)
Alt. 1 mL Sputum/phlegm (2-8 ºC - Refrigerate)

Request form:

Clinical information required.

Reference V.:

Negative

8120

M. TUBERCULOSIS (INTERFERON GAMMA), BLOOD

Method:

Enzyme-Linked Immunoassay.

Mounting:

Delivery period:5

Sample:

1 mL Plasma QuantiFERON (MITOGEN) (2-8 ºC - Refrigerate)
1 mL Plasma QuantiFERON (NIL) (2-8 ºC - Refrigerate)
1 mL Plasma QuantiFERON (TB ANTIGEN) (2-8 ºC - Refrigerate)

Sample extraction:

Use the tubes supplied by this laboratory.
Samples must come to our laboratory from Monday to Thursday. Wednesday is the last possible day for blood collection.

Reference V.:

Negative

Review:

21/06/2013

8215

MICROALBUMIN/CREATININE, URINE

Method:

Immunoturbidimetry.

Mounting:

Delivery period:1

Sample:

1 mL Urine (2-8 ºC - Refrigerate)

Sample extraction:

Second voided urine specimen.

Reference V.:

Cociente:

< 2.26 g/mol crea * 8.85 = mg/g crea

Concentración:

< 20.00 mg/L * 0.001 = g/L

Review:

09/04/2013

8237

MELATONIN, SERUM

Method:

Radioimmunoanalysis.

Mounting:

Delivery period:10

Sample:

1 mL Serum (-8 ºC - Freeze)

Transport:

Protect from light.

Reference V.:

Daytime <= to 30.00 pg/mL
Nighttime <= to 150.00 pg/mL

Review:

07/03/2006

8245

MYOTONIC DYSTROPHY TYPE 1 (DM1) (DMPK GENE), AMNIOTIC FLUID

Method:

PCR-Fragment length analysis+TP PCR.

Mounting:

Delivery period:25

Sample:

5 mL Amniotic fluid (12-20 ºC - Ambient Temp.)

Request form:

Clinical information required.

Reference V.:

Reported for each case

Review:

23/04/2018

8311

MOLECULAR VIROLOGY STUDY OF RESPIRATORY TRACT, BODY FLUID

Method:

Polymerase chain reaction.

Mounting:

Delivery period:10

Sample:

2 mL Nasopharingeous smear Vircell ® (2-8 ºC - Refrigerate)
Alt. 5 mL Nasopharyngeal aspiration (-8 ºC - Freeze)

Sample extraction:

Freeze specimen if more than 24 h passed since extraction.
Do not use swabs with wooden rod, swabs or calcium alginate gel transport.

Reference V.:

Negative
Negative
Negative
Negative

ADN Coronavirus:

Negative

ADN Enterovirus:

Negative

ADN Parainfluenza 1:

Negative

ADN Parainfluenza 2:

Negative

ADN Parainfluenza 3:

Negative

ADN Parainfluenza 4:

Negative

ARN Rinovirus:

Negative

Review:

23/04/2018

8320

MEVALONIC ACID, URINE

Method:

Gas Chromatography - Mass spectrometry.

Mounting:

Delivery period:20

Sample:

10 mL Urine (-8 ºC - Freeze)

Reference V.:

< 1.30 mmol/mol creat.

Review:

27/03/2012

8381

MYELOID PROGENITOR CELLS, BONE MARROW

Method:

In vitro culture.

Mounting:

Delivery period:31

Sample:

1 mL Bone marrow Heparin lithium (12-20 ºC - Ambient Temp.)

Reference V.:

CFU-E with Epo:

177.00 - 327.00 2x10Exp5 cel.

BFU-E with Epo:

102.00 - 186.00 2x10Exp5 cel.

Number of aggregates with FEC:

35.00 - 193.00 2x10Exp5 cel.

Number of colonies with FEC:

77.00 - 173.00 2x10Exp5 cel.

CFU-Meg with MCL:

28.30 - 46.50 2x10Exp5 cel.

8405

MYCOPLASMA PNEUMONIAE ANTIBODIES, IgM, CSF

Method:

Indirect Immunofluorescense.

Mounting:

Delivery period:15

Sample:

1 mL Cerebrospinal liquid (2-8 ºC - Refrigerate)

Reference V.:

Positive: > 20.01 Uarb/mL

Negative:

<= to 20.00 Uarb/mL

Review:

23/04/2018

8406

MYCOPLASMA PNEUMONIAE ANTIBODIES, IgG, CSF

Method:

Enzyme-Linked Immunoassay.

Mounting:

Delivery period:15

Sample:

1 mL Cerebrospinal liquid (2-8 ºC - Refrigerate)

Reference V.:

Positive: > 20.01 Uarb/mL

Negative:

<= to 20.00 Uarb/mL

Review:

23/04/2018

8487

MGT-30 (TITIN) ANTIBODIES, SERUM

Method:

Enzyme-Linked Immunoassay.

Mounting:

Delivery period:10

Sample:

0.5 mL Serum (2-8 ºC - Refrigerate)

Reference V.:

Negative

Review:

23/04/2018

8555

MARFAN SYNDROME (FBN1 GENE: NGS), BLOOD

Method:

Next Generation Sequencing (NGS).

Mounting:

Delivery period:45

Sample:

10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)

Request form:

Clinical information required.

Sample extraction:

Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.

Reference V.:

Reported for each case

Review:

15/03/2013

8630

MYCOBACTERIUM TUBERCULOSIS DNA, BIOPSY

Method:

Real Time PCR.

Mounting:

Delivery period:10

Sample:

1 Sample/s Biopsy (2-8 ºC - Refrigerate)

Reference V.:

Negative

Review:

11/02/2014

8670

MELANOMA CUTANEOUS MALIGNANT 2 (CDKN2A GENE: NGS), BLOOD

Method:

Next Generation Sequencing (NGS).

Mounting:

Delivery period:45

Sample:

10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)

Request form:

Clinical information required.

Sample extraction:

Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.

Reference V.:

Reported for each case

Review:

02/04/2009

8724

MA1 ANTIBODIES, SERUM

Method:

Immunoblot.

Mounting:

Delivery period:15

Sample:

1 mL Serum (2-8 ºC - Refrigerate)

Reference V.:

Negative

8748

MICROBIOLOGIC STUDY, ULTRAPURE DIALYSIS WATER

Method:

Membrane filtration and specific medium culture.

Mounting:

Delivery period:14

Sample:

500 mL Dialysis water (2-8 ºC - Refrigerate)

Sample extraction:

Specimen must be received within 24 h after extraction. Avoid collecting on the day before weekends or holidays.
Specimens must be delivered to the laboratory from Monday to Thursday and never on the eve of public holidays.

8749

MICROBIOLOGIC STUDY, ULTRAPURE DIALYSIS FLUID

Method:

Membrane filtration and specific medium culture.

Mounting:

Delivery period:14

Sample:

500 mL Dialysis water (2-8 ºC - Refrigerate)

Sample extraction:

Specimen must be received within 24 h after extraction. Avoid collecting on the day before weekends or holidays.
Specimens must be delivered to the laboratory from Monday to Thursday and never on the eve of public holidays.

iSO-13959 2014:

<= to 0.03 EU/mL
<= to 1.00 UFC/100 mL
<= to 10.00 UFC/100 mL

8750

MICROBIOLOGIC STUDY, HEMODIALYSIS MONITORS SAMPLES

Method:

Membrane filtration and specific medium culture.

Mounting:

Delivery period:14

Sample:

500 mL Dialysis water (2-8 ºC - Refrigerate)

Sample extraction:

Specimen must be received within 24 h after extraction. Avoid collecting on the day before weekends or holidays.
Specimens must be delivered to the laboratory from Monday to Thursday and never on the eve of public holidays.

iSO-13959 2014:

<= to 0.03 EU/mL
<= to 1.00 UFC/100 mL
<= to 10.00 UFC/100 mL

8812

METABOLISM ESTROGENS, URINE

Method:

Enzyme-Linked Immunoassay.

Mounting:

Delivery period:16

Sample:

10 mL Urine (2-8 ºC - Refrigerate)

Reference V.:

Ovulatory peak Females 4.00 - 43.40 ng/mg Creat
Females 4.70 - 25.70 ng/mg Creat
Postmenopause Females 3.50 - 7.50 ng/mg Creat
Luteal phase Females 7.90 - 28.50 ng/mg Creat
Postmenopause with HTS Females 3.40 - 21.20 ng/mg Creat
Females > 2.00
Postmenopause with HTS Females 0.30 - 76.10 ng/mg Creat
Folicular phase Females 3.40 - 22.80 ng/mg Creat
Females 1.30 - 18.20 ng/mg Creat
Postmenopause Females 2.00 - 5.80 ng/mg Creat
Luteal phase Females 4.60 - 24.20 ng/mg Creat

Review:

12/09/2013

8834

METHYLMALONIC ACID, URINE

Method:

High efficiency liquid chromatography - Mass spectrometry.

Mounting:

Delivery period:23

Sample:

10 mL Urine (-8 ºC - Freeze)

Sample extraction:

Freeze specimen immediately.

Reference V.:

Methylmalonic Acid /crea:

5.00 - 32.00 umol/g creat

8840

MAPROTILINE AND NORMAPROTILINE, SERUM

Method:

High efficiency liquid chromatography - Mass spectrometry.

Mounting:

Delivery period:6

Sample:

1 mL Serum (2-8 ºC - Refrigerate)
Alt. 1 mL Plasma Tripotassium EDTA (2-8 ºC - Refrigerate)

Therapeutic R.:

Maprotiline + Normaprotiline:

100.00 - 400.00 ug/L * 3.6045 = nmol/L

8855

METHYLPHENIDATE AND RITALINIC ACID, SERUM

Method:

High efficiency liquid chromatography - Mass spectrometry.

Mounting:

Delivery period:9

Sample:

1 mL Serum (2-8 ºC - Refrigerate)
Alt. 1 mL Plasma Heparin lithium (2-8 ºC - Refrigerate)

Reference V.:

Methylphenidate:

8.00 - 30.00 ug/L

Ritalinic Acid:

80.00 - 300.00 ug/L

8856

MUCOPOLYSACCHARIDES (SCREENING), URINE

Method:

Molecular absorption Spectrometry.

Mounting:

Delivery period:21

Sample:

10 mL Urine (-8 ºC - Freeze)

Request form:

Clinical information required.

Sample extraction:

First voided morning urine specimen.

Reference V.:

Both 0 6 Months 7.10 - 18.00 mg/mmol crea
Both 1 2 Years 1.90 - 6.70 mg/mmol crea
Both 11 15 Years 0.50 - 3.10 mg/mmol crea
Both 16 18 Years 0.10 - 2.10 mg/mmol crea
Both 3 6 Years 1.70 - 5.40 mg/mmol crea
Both 7 10 Years 1.00 - 4.30 mg/mmol crea
Both 7 11 Months 3.30 - 7.30 mg/mmol crea

GLYCOSAMINOGLYCANS/L:

Not established.

8874

MAYARO VIRUS SEROLOGIC STUDY (IgG+IgM), SERUM

Method:

Indirect Immunofluorescense.

Mounting:

Delivery period:10

Sample:

1 mL Serum (2-8 ºC - Refrigerate)

Reference V.:

MAYARO VIRUS ANTIBODIES IgM, SERUM:

Positive:

>= to 1/20 Titulo

Negative:

< 1/20 Titulo

MAYARO VIRUS ANTICOBODIES IgG, SERUM:

Positive:

>= to 1/20 Titulo

Negative:

< 1/20 Titulo

8903

MILLER-DIEKER SYNDROME (17p13.3 Del: FISH), BLOOD

Method:

Complementary DNA chain hybridization.

Mounting:

Delivery period:10

Sample:

5 mL Total blood Sodium heparin (12-20 ºC - Ambient Temp.)

Request form:

Clinical information required.

Sample extraction:

Do not use EDTA as an anticoagulant.

Reference V.:

Reported for each case

Review:

26/10/2010

8928

MACROPROLACTIN, SERUM

Method:

Polyethylene Glycol Precipitation

Mounting:

Delivery period:2

Sample:

1 mL Serum (2-8 ºC - Refrigerate)
Alt. 1 mL Plasma Heparin lithium (2-8 ºC - Refrigerate)
Alt. 1 mL Plasma Sodium heparin (2-8 ºC - Refrigerate)

Reference V.:

Macroprolactina:

Negative: >= to 40.00 %

Positive:

< 40.00 %

Prolactina polietilenglicol:

Not available

Prolactina:

Females > 15 Years 5.18 - 26.53 ug/L * 21.2 = mUI/mL
Males > 15 Years 3.46 - 19.40 ug/L * 21.2 = mUI/mL

8929

MIRTAZAPINE AND DESMETHYL MIRTAZAPINE, SERUM

Method:

High efficiency liquid chromatography - Mass spectrometry.

Mounting:

Delivery period:10

Sample:

1 mL Serum (2-8 ºC - Refrigerate)

Reference V.:

Desmetilmirtazapina:

Not available

Mirtazapina:

Not available

Therapeutic R.:

Mirtazapina+Desmetilmirtazapina:

50.00 - 300.00 ug/L

9202

MACROAMYLASE, SERUM

Method:

Polyethylene Glycol Precipitation

Mounting:

Delivery period:2

Sample:

1 mL Serum (2-8 ºC - Refrigerate)
Alt. 1 mL Plasma Heparin lithium (2-8 ºC - Refrigerate)
Alt. 1 mL Plasma Sodium heparin (2-8 ºC - Refrigerate)

Interpretation:

Negative: >= to 27.00 %

Positive:

< 27.00 %

Reference V.:

Not available

10011

METFORMINE, PLASMA

Method:

High efficiency liquid chromatography.

Mounting:

Delivery period:10

Sample:

1 mL Serum (2-8 ºC - Refrigerate)
Alt. 1 mL Plasma Tripotassium EDTA (2-8 ºC - Refrigerate)

Therapeutic R.:

0,5 - 2,5 g/day 0.16 - 1.00 mg/L

Review:

23/04/2018

10026

MULTIMERES OF FACTOR VON WILLEBRAND, PLASMA

Method:

Agarose gel electrophoresis.

Mounting:

Delivery period:15

Sample:

2 mL Plasma Sodium Citrate (-8 ºC - Freeze)

Reference V.:

Reported for each case

Review:

23/04/2018

10032

METHANOL, BLOOD

Method:

Gas chromatography - Detection with flame ionization

Mounting:

Delivery period:9

Sample:

2.1 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Alt. 2.1 mL Serum (2-8 ºC - Refrigerate)

Reference V.:

< 0.05 mmol/L * 32.0513 = mg/L

Review:

23/09/2010

10060

MILLER-DIEKER SYNDROME (Del 17p13.3: FISH), AMNIOTIC FLUID

Method:

Complementary DNA chain hybridization.

Mounting:

Delivery period:15

Sample:

10 mL Amniotic fluid (12-20 ºC - Ambient Temp.)

Request form:

Clinical information required.

Reference V.:

Reported for each case

10210

MULTIPLE ENDOCRINE NEOPLASIA TYPE 2A (RET GENE: NGS), BLOOD

Method:

Next Generation Sequencing (NGS).

Mounting:

Delivery period:45

Sample:

10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)

Request form:

Clinical information required.

Sample extraction:

Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.

Reference V.:

Reported for each case

Review:

02/03/2015

10245

MIANSERIN, SERUM

Method:

High efficiency liquid chromatography - Mass spectrometry.

Mounting:

Delivery period:8

Sample:

0.5 mL Plasma Tripotassium EDTA (-8 ºC - Freeze)
0.5 mL Serum (-8 ºC - Freeze)

Therapeutic R.:

30.00 - 120.00 ng/mL

Review:

23/04/2018

10247

MYCOPLASMA PNEUMONIAE DNA, BIOPSY

Method:

Real Time PCR.

Mounting:

Delivery period:11

Sample:

1 piece/s Biopsy (2-8 ºC - Refrigerate)

Reference V.:

Negative

Review:

06/03/2012

10257

METHADONE, SERUM

Method:

High efficiency liquid chromatography - Mass spectrometry.

Mounting:

Delivery period:7

Sample:

2 mL Serum (2-8 ºC - Refrigerate)

Therapeutic R.:

50.00 - 1000.00 ng/mL
80.00 - 200.00 ng/mL

Toxic C.:

> 1000.00 ng/mL
> 500.00 ng/mL

10291

METHYLPHENIDATE, URINE

Method:

Gas Chromatography - Mass spectrometry.

Mounting:

Delivery period:7

Sample:

5 mL Urine (2-8 ºC - Refrigerate)

Reference V.:

Negative

10375

METHYLCROTONYL-CoA CARBOXYLASE, FIBROBLASTES

Mounting:

Delivery period:105

Sample:

1 piece/s Skin Biopsy RPMI media (12-20 ºC - Ambient Temp.)

Sample extraction:

Analysis with special requirements. You should contact the laboratory before extraction and shipment of the sample.

Reference V.:

Reported for each case

10600

METHYLMALONIC ACIDURIA+HOMOCYSTINURIA (MMACHC GENE: KNOWN M.), BLOOD

Method:

PCR-Sequencing.

Mounting:

Delivery period:35

Sample:

5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)

Request form:

Clinical information required.

Sample extraction:

Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.

Reference V.:

Reported for each case

10601

METHYLMALONIC ACIDURIA+HOMOCYSTINURIA cbIC TYPE (MMACHC GENE: NGS), BLOOD

Method:

Next Generation Sequencing (NGS).

Mounting:

Delivery period:45

Sample:

10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)

Request form:

Clinical information required.

Sample extraction:

Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.

Reference V.:

Reported for each case

10699

MIOCLONIC DYSTONIA (SGCE GENE: MLPA), BLOOD

Method:

MLPA (Multiplex Ligation-dependent Probe Amplification).

Mounting:

Delivery period:35

Sample:

5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)

Request form:

Clinical information required.

Sample extraction:

Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.

Reference V.:

Reported for each case

10700

MIOCLONIC DYSTONIA (SGCE GENE: NGS), BLOOD

Method:

Next Generation Sequencing (NGS).

Mounting:

Delivery period:45

Sample:

5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)

Request form:

Clinical information required.

Sample extraction:

Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.

Reference V.:

Reported for each case

10704

MYOTONIC DYSTROPHY TYPE 2 (DM2) (ZNF9 GENE), BLOOD

Method:

TP-PCR.

Mounting:

Delivery period:65

Sample:

10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)

Request form:

Clinical information required.

Sample extraction:

Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.

Reference V.:

Reported for each case

Review:

17/05/2013

10775

MUCOPOLYSACCHARIDOSIS IH (IDUA GENE: SEQUENCING), BLOOD

Method:

PCR-Sequencing.

Mounting:

Delivery period:65

Sample:

10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)

Request form:

Clinical information required.

Sample extraction:

Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.

Reference V.:

Reported for each case

Review:

14/09/2012

10776

MUCOPOLYSACCHARIDOSIS IH (IDUA GENE: KNOWN MUTATION), BLOOD

Method:

PCR-Sequencing.

Mounting:

Delivery period:35

Sample:

5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)

Request form:

Clinical information required.

Sample extraction:

Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.

Reference V.:

Reported for each case

10787

MUCOPOLYSACCHARIDOSIS TYPE IIIB (NAGLU GENE: KNOWN MUTATION), BLOOD

Method:

PCR-Sequencing.

Mounting:

Delivery period:35

Sample:

5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)

Request form:

Clinical information required.

Sample extraction:

Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.

Reference V.:

Reported for each case

10794

MACROTHROMBOCYTOPENIA (MYH9 GENE: NGS), BLOOD

Method:

Next Generation Sequencing (NGS).

Mounting:

Delivery period:40

Sample:

10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)

Request form:

Clinical information required.

Sample extraction:

Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.

Reference V.:

Reported for each case

10795

MARFAN SYNDROME (FBN1 AND TGFBR2 GENES: MLPA), BLOOD

Method:

MLPA (Multiplex Ligation-dependent Probe Amplification).

Mounting:

Delivery period:45

Sample:

10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)

Request form:

Clinical information required.

Sample extraction:

Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.

Reference V.:

Reported for each case

10796

MARFAN SYNDROME (FBN1 GENE: KNOWN MUTATION), BLOOD

Method:

PCR-Sequencing.

Mounting:

Delivery period:35

Sample:

5 mL Total blood Tripotassium EDTA (12-20 ºC - Ambient Temp.)

Request form:

Clinical information required.

Sample extraction:

Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.

Reference V.:

Reported for each case

Review:

02/10/2012

10798

MULTIPLE HEREDITARY I EXOSTOSES (EXT1 GENE: NGS), BLOOD

Method:

Next Generation Sequencing (NGS).

Mounting:

Delivery period:45

Sample:

10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)

Request form:

Clinical information required.

Sample extraction:

Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.

Reference V.:

Reported for each case

10799

MARINESCO-SJOGREN SYNDROME (SIL1 GENE: NGS), BLOOD

Method:

Next Generation Sequencing (NGS).

Mounting:

Delivery period:45

Sample:

10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)

Request form:

Clinical information required.

Sample extraction:

Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.

Reference V.:

Reported for each case

10800

McARDLE DISEASE (PYGM GENE: NGS), BLOOD

Method:

Next Generation Sequencing (NGS).

Mounting:

Delivery period:45

Sample:

10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)

Request form:

Clinical information required.

Sample extraction:

Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.

Reference V.:

Reported for each case

10801

McARDLE DISEASE (PYGM GENE: KNOWN MUTATION), BLOOD

Method:

PCR-Sequencing.

Mounting:

Delivery period:35

Sample:

5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)

Request form:

Clinical information required.

Sample extraction:

Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.

Reference V.:

Reported for each case

10802

MECKEL SYNDROME 1 (MKS1 GENE: NGS), BLOOD

Method:

Next Generation Sequencing (NGS).

Mounting:

Delivery period:45

Sample:

10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)

Request form:

Clinical information required.

Sample extraction:

Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.

Reference V.:

Reported for each case

10803

MECKEL SYNDROME 3 (TMEM67 GENE: NGS), BLOOD

Method:

Next Generation Sequencing (NGS).

Mounting:

Delivery period:45

Sample:

10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)

Request form:

Clinical information required.

Sample extraction:

Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.

Reference V.:

Reported for each case

10804

MELAS SYNDROME (MT-TL1 GENE : SEQUENCING), BLOOD

Method:

PCR-Sequencing.

Mounting:

Delivery period:35

Sample:

10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)

Request form:

Clinical information required.

Sample extraction:

Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.

Reference V.:

Reported for each case

Review:

23/04/2018

10805

MERRF SYNDROME (MT-TK GENE: A8344G MUTATION), BLOOD

Method:

PCR-Sequencing.

Mounting:

Delivery period:35

Sample:

5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)

Request form:

Clinical information required.

Sample extraction:

Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.

Reference V.:

Reported for each case

10817

MYOFIBRILLAR MYOPATHY (DES GENE: NGS), BLOOD

Method:

Next Generation Sequencing (NGS).

Mounting:

Delivery period:45

Sample:

10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)

Request form:

Clinical information required.

Sample extraction:

Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.

Reference V.:

Reported for each case

10818

MYOTUBULAR MYOPATHY X LINKED (MTM1 GENE: KNOWN MUTATION), BLOOD

Method:

PCR-Sequencing.

Mounting:

Delivery period:35

Sample:

5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)

Request form:

Clinical information required.

Sample extraction:

Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.

Reference V.:

Reported for each case

10819

MYOTUBULAR MYOPATHY X LINKED (MTM1 GENE: NGS), BLOOD

Method:

Next Generation Sequencing (NGS).

Mounting:

Delivery period:45

Sample:

10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)

Request form:

Clinical information required.

Sample extraction:

Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.

Reference V.:

Reported for each case

10871

MUCOPOLYSACCHARIDOSIS TYPE IIIA (SGSH GENE: NGS), BLOOD

Method:

Next Generation Sequencing (NGS).

Mounting:

Delivery period:45

Sample:

10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)

Request form:

Clinical information required.

Sample extraction:

Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.

Reference V.:

Reported for each case

10872

MUCOPOLYSACCHARIDOSIS TYPE IIIA (SGSH GENE: KNOWN MUTATION), BLOOD

Method:

PCR-Sequencing.

Mounting:

Delivery period:35

Sample:

5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)

Request form:

Clinical information required.

Sample extraction:

Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.

Reference V.:

Reported for each case

10873

MULTIPLE ENDOCRINE NEOPLASIA TYPE 2B (RET GENE: KNOWN MUTATION), BLOOD

Method:

PCR-Sequencing.

Mounting:

Delivery period:35

Sample:

5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)

Request form:

Clinical information required.

Sample extraction:

Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.

Reference V.:

Reported for each case

10888

MITOCHONDRIAL NON SYNDROMIC DEAFNESS (MTRNR1 GENE: SEQ.), BLOOD

Method:

PCR-Sequencing.

Mounting:

Delivery period:65

Sample:

10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)

Request form:

Clinical information required.

Sample extraction:

Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.

Reference V.:

Reported for each case

10904

MULTIPLE ENDOCRINE NEOPLASIA TYPE 2B (RET GENE: NGS), BLOOD

Method:

Next Generation Sequencing (NGS).

Mounting:

Delivery period:45

Sample:

10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)

Request form:

Clinical information required.

Sample extraction:

Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.

Reference V.:

Reported for each case

10934

mdr1 GENE (MULTIDRUG RESISTANCE GENE), BONE MARROW

10936

MULTIPLE ENDOCRINE NEOPLASIA TYPE 1 (MEN1 GENE: MLPA), BLOOD

Method:

MLPA (Multiplex Ligation-dependent Probe Amplification)

Mounting:

Delivery period:35

Sample:

5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)

Request form:

Clinical information required.

Sample extraction:

Do not send specimens with heparin because they inhibit the polymerase of PCR.

Reference V.:

Reported for each case

10938

MULTIPLE ENDROCRINE NEOPLASIA TYPE 1 (MEN1 GENE: KNOWN M.), BLOOD

Method:

PCR-Sequencing.

Mounting:

Delivery period:35

Sample:

5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)

Request form:

Clinical information required.

Sample extraction:

Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.

Reference V.:

Reported for each case

Review:

23/04/2018

10967

MALONIC ACIDURIA (MLYCD GENE), CHORIONIC VILLI

Method:

PCR-Sequencing.

Mounting:

Delivery period:25

Sample:

0.01 g Corial villus RPMI media (12-20 ºC - Ambient Temp.)

Request form:

Clinical information required.

Sample extraction:

Use the tubes supplied by this laboratory.
It´s necessary to send 5 mL maternal EDTA blood in order to discard a maternal contamination.

Reference V.:

Reported for each case

10990

MYOTONIC DYSTROPHY TYPE 1 (DM1) (DMPK GENE), CHORIONIC VILLI

Method:

PCR-Fragment length analysis+TP PCR.

Mounting:

Delivery period:25

Sample:

0.01 g Corial villus (12-20 ºC - Ambient Temp.)

Request form:

Clinical information required.

Sample extraction:

Use the tubes supplied by this laboratory.
It´s necessary to send 5 mL maternal EDTA blood in order to discard a maternal contamination.

Reference V.:

Reported for each case

10991

MUSCULAR DYSTROPHY MEROSIN-DEFICIENT (LAMA2 GENE), C. VILLI

Method:

PCR-Sequencing.

Mounting:

Delivery period:25

Sample:

0.01 g Corial villus (12-20 ºC - Ambient Temp.)

Request form:

Clinical information required.

Sample extraction:

Use the tubes supplied by this laboratory.
It´s necessary to send 5 mL maternal EDTA blood in order to discard a maternal contamination.

Reference V.:

Reported for each case

11008

MUCOPOLYSACCHARIDOSIS TYPE I (IDUA GENE), AMNIOTIC FLUID

Method:

PCR-Sequencing.

Mounting:

Delivery period:25

Sample:

10 mL Amniotic fluid (12-20 ºC - Ambient Temp.)

Request form:

Clinical information required.

Sample extraction:

It´s necessary to send 5 mL maternal EDTA blood in order to discard a maternal contamination.

Reference V.:

Reported for each case

11013

MULTIPLE ENDOCRINE NEOPLASIA TYPE 2A (RET GENE: KNOWN MUTATION), BLOOD

Method:

PCR-Sequencing.

Mounting:

Delivery period:35

Sample:

5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)

Request form:

Clinical information required.

Sample extraction:

Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.

Reference V.:

Reported for each case

11015

MUCOPOLYSACCHARIDOSIS TYPE IIIB (NAGLU GENE), AMNIOTIC FLUID

Method:

PCR-Sequencing.

Mounting:

Delivery period:25

Sample:

10 mL Amniotic fluid (12-20 ºC - Ambient Temp.)

Request form:

Clinical information required.

Sample extraction:

It´s necessary to send 5 mL maternal EDTA blood in order to discard a maternal contamination.

Reference V.:

Reported for each case

11035

MLL/AF4 t(4;11) QUALITATIVE REARRANGEMENT, BLOOD

Method:

RT-PCR+ Fragment.lenght analysis.

Mounting:

Delivery period:17

Sample:

5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)

Request form:

Clinical information required.

Sample extraction:

Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.
Specimens must be delivered to the laboratory from Monday to Thursday and never on the eve of public holidays.

Reference V.:

Reported for each case

11058

MUCOPOLYSACCHARIDOSIS TYPE IIIB (NAGLU GENE: NGS), BLOOD

Method:

Next Generation Sequencing (NGS).

Mounting:

Delivery period:45

Sample:

10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)

Request form:

Clinical information required.

Sample extraction:

Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.

Reference V.:

Reported for each case

11083

McCUNE-ALBRIGTH SYNDROME (GNAS GENE: NGS), BLOOD

Method:

Next Generation Sequencing (NGS).

Mounting:

Delivery period:45

Sample:

10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)

Request form:

Clinical information required.

Sample extraction:

Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.

Reference V.:

Reported for each case

11091

MALIGNANT HYPERTHERMIA (RYR1 GENE: NGS), BLOOD

Method:

Next Generation Sequencing (NGS).

Mounting:

Delivery period:45

Sample:

10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)

Request form:

Clinical information required.

Sample extraction:

Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.

Reference V.:

Reported for each case

11100

MATTHEW-WOOD SYNDROME (STRA6 GENE: NGS), BLOOD

Method:

Next Generation Sequencing (NGS).

Mounting:

Delivery period:45

Sample:

10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)

Request form:

Clinical information required.

Sample extraction:

Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.

Reference V.:

Reported for each case

11105

MILROY DISEASE (FLT4 GENE: NGS), BLOOD

Method:

Next Generation Sequencing (NGS).

Mounting:

Delivery period:45

Sample:

10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)

Request form:

Clinical information required.

Sample extraction:

Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.

Reference V.:

Reported for each case

11106

MELANOMA AND NEURAL SYSTEM TUMOUR SYNDROME (CDKN2A GENE: NGS), BLOOD

Method:

Next Generation Sequencing (NGS).

Mounting:

Delivery period:45

Sample:

10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)

Request form:

Clinical information required.

Sample extraction:

Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.

Reference V.:

Reported for each case

11109

MYOTUBULAR MYOPATHY X LINKED (MTM1 GENE: MLPA), BLOOD

Method:

MLPA (Multiplex Ligation-dependent Probe Amplification).

Mounting:

Delivery period:35

Sample:

10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)

Request form:

Clinical information required.

Sample extraction:

Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.

Reference V.:

Reported for each case

11114

MULTIPLE HEREDITARY II EXOSTOSES (EXT2 GENE: NGS), BLOOD

Method:

Next Generation Sequencing (NGS).

Mounting:

Delivery period:45

Sample:

10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)

Request form:

Clinical information required.

Sample extraction:

Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.

Reference V.:

Reported for each case

11139

MUSCULAR DYSTROPHY MEROSIN-DEFICIENT (LAMA2 GENE: NGS), BLOOD

Method:

Next Generation Sequencing (NGS).

Mounting:

Delivery period:45

Sample:

10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)

Request form:

Clinical information required.

Sample extraction:

Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.

Reference V.:

Reported for each case

11168

MYCN GENE (2p24.3), BLOOD

Method:

PCR-Sequencing.

Mounting:

Delivery period:21

Sample:

5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)

Request form:

Clinical information required.

Sample extraction:

Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.

Reference V.:

Reported for each case

11192

METHYLCROTONYLGLYCINURIA TYPE II (MCC2 GENE: NGS.), FIBROBLASTS

Method:

Next Generation Sequencing (NGS)

Mounting:

Delivery period:110

Sample:

1 piece/s Skin Biopsy RPMI media (12-20 ºC - Ambient Temp.)

Request form:

Clinical information required.

Sample extraction:

Analysis with special requirements. You should contact the laboratory before extraction and shipment of the sample.

Reference V.:

Reported for each case

Review:

03/09/2012

11193

METHYLCROTONYLGLYCINURIA TYPE I (MCCC1 GENE: NGS), FIBROBLASTS

Method:

Next Generation Sequencing (NGS)

Mounting:

Delivery period:110

Sample:

1 piece/s Skin Biopsy RPMI media (12-20 ºC - Ambient Temp.)

Request form:

Clinical information required.

Sample extraction:

Analysis with special requirements. You should contact the laboratory before extraction and shipment of the sample.

Reference V.:

Reported for each case

Review:

03/09/2012

11206

METHYLCROTONYLGLYCINURIA TYPE I (MCCC1 GENE: MLPA), FIBROBLASTS

Method:

MLPA (Multiplex Ligation-dependent Probe Amplification).

Mounting:

Delivery period:110

Sample:

1 piece/s Skin Biopsy RPMI media (12-20 ºC - Ambient Temp.)

Request form:

Clinical information required.

Sample extraction:

Analysis with special requirements. You should contact the laboratory before extraction and shipment of the sample.

Reference V.:

Reported for each case

11212

MUCOPOLYSACCHARIDOSIS TYPE II (IDS GENE: NGS), BLOOD

Method:

Next Generation Sequencing (NGS).

Mounting:

Delivery period:45

Sample:

10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)

Request form:

Clinical information required.

Sample extraction:

Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.

Reference V.:

Reported for each case

11227

M3 MITOCHONDRIAL ANTIBODIES, SERUM

Method:

Indirect Immunofluorescense.

Mounting:

Delivery period:6

Sample:

1 mL Serum (2-8 ºC - Refrigerate)

Interpretation:

Positive: >= to 1/40 Titulo

Negative:

< 1/40 Titulo

11228

M4 MITOCHONDRIAL ANTIBODIES, SERUM

Method:

Immunoblot.

Mounting:

Delivery period:5

Sample:

1 mL Serum (2-8 ºC - Refrigerate)

Interpretation:

Negative

Review:

07/09/2012

11229

M5 MITOCHONDRIAL ANTIBODIES, SERUM

Method:

Indirect Immunofluorescense.

Mounting:

Delivery period:6

Sample:

1 mL Serum (2-8 ºC - Refrigerate)

Interpretation:

Positive: >= to 1/40 Titulo

Negative:

< 1/40 Titulo

11230

M9 MITOCHONDRIAL ANTIBODIES, SERUM

Method:

Immunoblot.

Mounting:

Delivery period:5

Sample:

1 mL Serum (2-8 ºC - Refrigerate)

Interpretation:

Negative

Review:

07/09/2012

11410

MITOTANE, SERUM

Method:

Gas Chromatography - Mass spectrometry.

Mounting:

Delivery period:6

Sample:

1 mL Serum (-8 ºC - Freeze)
Alt. 1 mL Plasma Tripotassium EDTA (-8 ºC - Freeze)

Therapeutic R.:

10.00 - 20.00 mg/L

Review:

23/04/2018

11560

MELATONIN, SALIVA

Method:

Radioimmunoanalysis.

Mounting:

Delivery period:15

Sample:

1 mL Saliva (-8 ºC - Freeze)

Reference V.:

Daytime < 5.00 pg/mL
Nighttime > 10.00 pg/mL

Review:

12/02/2015

11573

MUCOPOLYSACCHARIDOSIS TYPE IVA (IGALNS GENE: NGS), BLOOD

Method:

Next Generation Sequencing (NGS).

Mounting:

Delivery period:45

Sample:

10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)

Request form:

Clinical information required.

Sample extraction:

Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.

Reference V.:

Reported for each case

Review:

24/04/2018

11574

MUCOPOLYSACCHARIDOSIS TYPE IVA (IGALNS GENE: KNOWN MUTATION), BLOOD

Method:

PCR-Sequencing.

Mounting:

Delivery period:35

Sample:

5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)

Request form:

Clinical information required.

Sample extraction:

Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.

Reference V.:

Reported for each case

Review:

24/04/2018

11606

MYCOPLASMA HOMINIS DNA, URETHRAL EXUDATE

Method:

Real Time PCR.

Mounting:

Delivery period:8

Sample:

1 mL Urethral exudate (2-8 ºC - Refrigerate)

Reference V.:

Negative

Review:

30/10/2013

11645

MIELINE ASSOCIATED GLICOPROTEIN (MAG) IgM ANTIBODIES, CSF

Method:

Indirect Immunofluorescense.

Mounting:

Delivery period:10

Sample:

0.5 mL Cerebrospinal liquid (2-8 ºC - Refrigerate)

Interpretation:

Positive: >= to 1/5 Titulo

Negative:

< 1/5 Titulo

Review:

23/06/2013

11650

MA1 ANTIBODIES, CSF

Method:

Immunoblot.

Mounting:

Delivery period:15

Sample:

1 mL Cerebrospinal liquid (2-8 ºC - Refrigerate)

Reference V.:

Negative

11690

MEASLES VIRUS ANTIBODIES IgG, CSF

11691

MEASLES VIRUS ANTIBODIES IgM, CSF

11765

MOLYBDENUM, BLOOD

Method:

Inductively coupled plasma mass spectrometry

Mounting:

Delivery period:10

Sample:

7.5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)
Alt. 7.5 mL Total blood Heparin lithium (2-8 ºC - Refrigerate)
Alt. 7.5 mL Total blood Sodium heparin (2-8 ºC - Refrigerate)

Sample extraction:

Metal-free tubes (special for the determination of oligoelements) must be used.

Reference V.:

8.03 - 81.96 nmol/L * 0.09594 = ug/L

Review:

24/04/2018

11816

MITOCHONDRIAL NON SYNDROMIC DEAFNESS (MTRNR1 GENE: KNOWN M.), BLOOD

Method:

PCR-Sequencing.

Mounting:

Delivery period:35

Sample:

5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)

Request form:

Clinical information required.

Sample extraction:

Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.

Reference V.:

Reported for each case

Review:

24/04/2018

11854

MYOFIBRILLAR MYOPATHY 3 (MYOT GENE: NGS), BLOOD

Method:

Next Generation Sequencing (NGS).

Mounting:

Delivery period:45

Sample:

10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)

Request form:

Clinical information required.

Sample extraction:

Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.

Reference V.:

Reported for each case

Review:

24/04/2018

11873

M2-PIRUVATE KINASE, PLASMA

Method:

Enzyme-Linked Immunoassay.

Mounting:

Delivery period:15

Sample:

1 mL Plasma Tripotassium EDTA (-8 ºC - Freeze)

Reference V.:

0.00 - 15.00 U/mL

11946

mGluR1 NEURONAL ANTIBODIES, CSF

Method:

Immunohistochemistry

Mounting:

Delivery period:21

Sample:

0.5 mL Cerebrospinal liquid (2-8 ºC - Refrigerate)

Reference V.:

Negative

Review:

02/05/2014

11987

MYB GENE REARRANGEMENT (6q23 REGION: FISH), BONE MARROW

Method:

Complementary DNA chain hybridization.

Mounting:

Delivery period:11

Sample:

3 mL Bone marrow Sodium heparin RPMI media (12-20 ºC - Ambient Temp.)

Request form:

Clinical information required.

Sample extraction:

Use the tubes supplied by this laboratory.

Reference V.:

Reported for each case

11991

MORPHINE, SERUM

Method:

High efficiency liquid chromatography - Mass spectrometry.

Mounting:

Delivery period:6

Sample:

2 mL Serum (2-8 ºC - Refrigerate)

Sample extraction:

In case of oral therapy, the serum sample should be obtained 3 to 5 hours after the last administration.

Therapeutic R.:

10.00 - 100.00

Review:

24/07/2014

14240

MUSK ANTIBODIES, SERUM

Method:

Radioimmunoanalysis.

Mounting:

Delivery period:11

Sample:

1 mL Serum (2-8 ºC - Refrigerate)

Reference V.:

< 0.40 U/mL

Review:

18/11/2014

14313

MGMT GENE PROMOTOR METHYLATION STUDY, PARAFFIN TISSUE

Method:

MS-PCR (Methylation specífic-PCR)

Mounting:

Delivery period:45

Request form:

Clinical information required.

Reference V.:

Reported for each case

14314

MYCOBACTERIUM spp. DNA, BONE MARROW

Method:

PCR-Sequencing.

Mounting:

Delivery period:10

Sample:

2 mL Bone marrow Tripotassium EDTA (2-8 ºC - Refrigerate)

Reference V.:

Negative

Review:

24/04/2018

14323

MYELOPROLIFERATIVE CHRONIC SYNDROME (EXON 9 CALR GENE), BLOOD

Method:

PCR-Sequencing.

Mounting:

Delivery period:25

Sample:

5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)

Request form:

Clinical information required.

Sample extraction:

Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.

Reference V.:

Reported for each case

14380

mGluR5 NEURONAL ANTIBODIES, SERUM

Method:

Immunohistochemistry

Mounting:

Delivery period:21

Sample:

1 mL Serum (2-8 ºC - Refrigerate)

Reference V.:

Negative

14381

MYELIN ANTIBODIES IgM, CSF

Method:

Indirect Immunofluorescense.

Mounting:

Delivery period:10

Sample:

0.5 mL Cerebrospinal liquid (2-8 ºC - Refrigerate)

Reference V.:

Negative

14392

MYOGLOBIN, URINE

Method:

Immunochemiluminiscence.

Mounting:

Delivery period:2

Sample:

1 mL Urine (2-8 ºC - Refrigerate)

Sample extraction:

Adjust urine at pH 8 - 9 with0,1 mL of a carbonate sodic 10 % solution.

Reference V.:

<= to 1.20 nmol/L * 17.5439 = ng/mL

Review:

02/06/2015

14604

MORPHIN (SCREENING), URINE

Method:

Immunochromatography.

Mounting:

Delivery period:1

Sample:

3 mL Urine (2-8 ºC - Refrigerate)

Reference V.:

Negative

Discriminant V.:

300.00 ug/L

14605

METAMPHETAMINES (SCREENING), URINE

Method:

Enzyme-Linked Immunoassay.

Mounting:

Delivery period:1

Sample:

3 mL Urine (2-8 ºC - Refrigerate)

Reference V.:

Negative

Discriminant V.:

500

14641

mGluR5 NEURONAL ANTIBODIES, CSF

Method:

Immunohistochemistry

Mounting:

Delivery period:21

Sample:

0.5 mL Cerebrospinal liquid (2-8 ºC - Refrigerate)

Reference V.:

Negative

14644

mGluR1 NEURONAL ANTIBODIES, SERUM

Method:

Immunohistochemistry

Mounting:

Delivery period:21

Sample:

1 mL Serum (2-8 ºC - Refrigerate)

Reference V.:

Negative

14649

MDA-5 - CADM-140 ANTIBODIES, SERUM

Method:

Enzyme-Linked Immunoassay + Inmunoblot.

Mounting:

Delivery period:18

Sample:

1 mL Serum (2-8 ºC - Refrigerate)

Reference V.:

Negative

14665

MYCOBACTERIUM spp. DNA, BIOPSY

Method:

PCR-Sequencing.

Mounting:

Delivery period:15

Sample:

1 piece/s Biopsy (2-8 ºC - Refrigerate)

Reference V.:

Negative

Review:

25/04/2018

14667

METAQUALONE (SCREENING), URINE

Method:

Qualitative Immunochromatographie.

Mounting:

Delivery period:6

Sample:

10 mL Urine (2-8 ºC - Refrigerate)

Discriminant V.:

300.00 ug/L

Reference V.:

Negative

14686

METHYLCROTONYLGLYCINURIA TYPE II (MCC2 GENE: MLPA), FIBROBLASTS

Method:

MLPA (Multiplex Ligation-dependent Probe Amplification).

Mounting:

Delivery period:110

Sample:

1 piece/s Skin Biopsy RPMI media (12-20 ºC - Ambient Temp.)

Request form:

Clinical information required.

Sample extraction:

Analysis with special requirements. You should contact the laboratory before extraction and shipment of the sample.

Reference V.:

Reported for each case

14690

METHYLCROTONYLGLYCINURIE TYPE II (GÈNE MCCC2: KNOWN M.), BLOOD

Method:

PCR-Sequencing.

Mounting:

Delivery period:35

Sample:

5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)

Request form:

Clinical information required.

Sample extraction:

Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.

Reference V.:

Reported for each case

14691

METHYLCROTONYLGLYCINURIE TYPE I (MCCC1 GENE: KNOWN M.), BLOOD

Method:

PCR-Sequencing.

Mounting:

Delivery period:35

Sample:

5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)

Request form:

Clinical information required.

Sample extraction:

Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.

Reference V.:

Reported for each case

14775

MAGNESIUM (Absorption molecular), SERUM

Method:

Molecular absorption Spectrometry.

Mounting:

Delivery period:3

Sample:

1 mL Serum (2-8 ºC - Refrigerate)

Sample extraction:

Separate serum as soon as possible.

Reference V.:

Both 1 5 Years 0.70 - 0.95 mmol/L * 2.43072 = mg/dL
Both > 90 Years 0.70 - 0.95 mmol/L * 2.43072 = mg/dL
Both 5 12 Years 0.70 - 0.86 mmol/L * 2.43072 = mg/dL
Both 1 12 Months 0.65 - 0.88 mmol/L * 2.43072 = mg/dL
Both 1 30 Days 0.62 - 0.91 mmol/L * 2.43072 = mg/dL
Both 20 60 Years 0.66 - 1.07 mmol/L * 2.43072 = mg/dL
Both 12 20 Years 0.70 - 0.91 mmol/L * 2.43072 = mg/dL
Both 60 90 Years 0.66 - 0.99 mmol/L * 2.43072 = mg/dL

14777

METHADONE CONFIRMATORY, URINE

Method:

Gas Chromatography - Mass spectrometry.

Mounting:

Delivery period:10

Sample:

15 mL Urine (2-8 ºC - Refrigerate)

Discriminant V.:

0.20 ug/mL

Reference V.:

Negative

14916

MULTIPLE ENDOCRINE NEO 2 (RET GENE: EXONS 10,11,13,14,15 and 16), BLOOD

Method:

Next Generation Sequencing (NGS).

Mounting:

Delivery period:45

Sample:

5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)

Request form:

Clinical information required.

Sample extraction:

Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.

Reference V.:

Reported for each case

15329

MYCOPLASMA PNEUMONIAE ANTIBODIES, IgG, SERUM

Method:

Immunochemiluminiscence.

Mounting:

Delivery period:5

Sample:

1 mL Serum (2-8 ºC - Refrigerate)

Request form:

Please mark specimens clearly as "acute" or "convalescent."

Interpretation:

Positive: >= to 10.00 UA/mL

Negative:

< 10.00 UA/mL

R.Values:

The study of two serum specimens obtained at an interval of 14-21 days is recommended to confirm recent infection.

15330

MYCOPLASMA PNEUMONIAE ANTIBODIES, IgM, SERUM

Method:

Immunochemiluminiscence.

Mounting:

Delivery period:5

Sample:

1 mL Serum (2-8 ºC - Refrigerate)

Interpretation:

Negative: < 10.00 Indice

Positive:

>= to 10.00 Indice

15331

MEASLES VIRUS ANTIBODIES, IgG, SERUM

Method:

Immunochemiluminiscence.

Mounting:

Delivery period:5

Sample:

1 mL Serum (2-8 ºC - Refrigerate)
Alt. 1 mL Plasma Tripotassium EDTA (2-8 ºC - Refrigerate)
Alt. 1 mL Plasma Sodium heparin (2-8 ºC - Refrigerate)

Interpretation:

Indeterminate: 13.5 - 16.5 Uarb/mL

Positive:

> 16.5 Uarb/mL

Negative:

< 13.5 Uarb/mL

15332

MEASLES VIRUS ANTIBODIES IgM, SERUM

Method:

Immunochemiluminiscence.

Mounting:

Delivery period:5

Sample:

1 mL Serum (2-8 ºC - Refrigerate)
Alt. 1 mL Plasma Tripotassium EDTA (2-8 ºC - Refrigerate)
Alt. 1 mL Plasma Sodium heparin (2-8 ºC - Refrigerate)

Interpretation:

Positive: >= to 1.10 Indice

Negative:

< 0.90 Indice

Indeterminate:

0.90 - 1.09 Indice

15371

M. TUBERCULOSIS RESISTANCE ANTIBIOTICS FIRST LINE, CULTURE

Method:

Polymerase chain reaction.

Mounting:

Delivery period:12

Sample:

1 mL Colonies (pure culture) (12-20 ºC - Ambient Temp.)

Reference V.:

Reported for each case

15372

M. TUBERCULOSIS RESISTANCE ANTIBIOTICS SECOND LINE, CULTURE

Method:

Polymerase chain reaction.

Mounting:

Delivery period:12

Sample:

1 mL Colonies (pure culture) (12-20 ºC - Ambient Temp.)

Reference V.:

Reported for each case

15410

MYCOPLASMA HOMINIS DNA, GENITAL SMEAR

Method:

Real Time PCR.

Mounting:

Delivery period:8

Sample:

1 Sample/s Smear (2-8 ºC - Refrigerate)

Reference V.:

Negative

15448

MULTIPLE ENDOCRINE NEOPLASIA 2B 8RET GENE: MLPA), BLOOD

Method:

MLPA (Multiplex Ligation-dependent Probe Amplification)

Mounting:

Delivery period:35

Sample:

5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)

Request form:

Clinical information required.

Sample extraction:

Do not send specimens with heparin because they inhibit the polymerase of PCR.

Reference V.:

Reported for each case

15557

MYCOBACTERIUM TUBERCULOSIS COMPLEX ADN, SPUTUM

Method:

Real Time PCR.

Mounting:

Delivery period:6

Sample:

2 mL Sputum/phlegm (2-8 ºC - Refrigerate)

Reference V.:

Negative

R.Values:

This study only detects the following Mycobacterium species: M. tuberculosis, M. bovis, M. africanum and M. microti.

15588

MYCOBACTERIUM TUBERCULOSIS COMPLEX ADN, PLEURAL FLUID

Method:

Real Time PCR.

Mounting:

Delivery period:11

Sample:

2 mL Pleural fluid (2-8 ºC - Refrigerate)

Reference V.:

Negative

R.Values:

This study only detects the following Mycobacterium species: M. tuberculosis, M. bovis, M. africanum and M. microti.

15589

MYCOBACTERIUM TUBERCULOSIS COMPLEX ADN, URINE

Method:

Real Time PCR.

Mounting:

Delivery period:11

Sample:

5 mL Urine (2-8 ºC - Refrigerate)

Reference V.:

Negative

R.Values:

This study only detects the following Mycobacterium species: M. tuberculosis, M. bovis, M. africanum and M. microti.

15590

MYCOBACTERIUM TUBERCULOSIS COMPLEX ADN, BLOOD

Method:

Real Time PCR.

Mounting:

Delivery period:11

Sample:

2 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)

Reference V.:

Negative

R.Values:

This study only detects the following Mycobacterium species: M. tuberculosis, M. bovis, M. africanum and M. microti.

15596

MYNUTRIGENES, BLOOD

Mounting:

Delivery period:11

Sample:

1 Smear Buccal smear. (2-8 ºC - Refrigerate)
10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)

Reference V.:

Reported for each case

15620

MAST CELL DISEASE (C-KIT GENE: EXON 17), BLOOD

Method:

PCR-Sequencing.

Mounting:

Delivery period:35

Sample:

5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)

Request form:

Clinical information required.

Sample extraction:

Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.

Reference V.:

Reported for each case

15622

MYELOID ACUTE LEUKEMIA (c-KIT GENE: EXONS 8, 10, 11 and 17), BLOOD

Method:

PCR-Sequencing.

Mounting:

Delivery period:35

Sample:

5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)

Request form:

Clinical information required.

Sample extraction:

Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.

Reference V.:

Reported for each case

15665

MPO (MYELOPEROXIDASE) ANTIBODIES, SERUM

Method:

Multiplex Fluorometric ImmunoAssay

Mounting:

Delivery period:2

Sample:

1 mL Serum (2-8 ºC - Refrigerate)

Interpretation:

Positive: >= to 1.00 IA

Negative:

< 1.00 IA

15710

MYCOBACTERIUM TUBERCULOSIS COMPLEX ADN, BRONCHOALVEOLAR LAVAGE

Method:

Real Time PCR.

Mounting:

Delivery period:11

Sample:

2 mL BAL (2-8 ºC - Refrigerate)

Reference V.:

Negative

15748

MIDAZOLAM, SERUM

Method:

High efficiency liquid chromatography - Mass spectrometry.

Mounting:

Delivery period:8

Sample:

1 mL Serum (2-8 ºC - Refrigerate)
Alt. 1 mL Plasma Tripotassium EDTA (2-8 ºC - Refrigerate)

Therapeutic R.:

40.00 - 100.00 µg/L * 0.00307 = µmol/L

15750

MEDAZEPAM, SERUM

Method:

High efficiency liquid chromatography - Mass spectrometry.

Mounting:

Delivery period:8

Sample:

1 mL Serum (2-8 ºC - Refrigerate)
Alt. 1 mL Plasma Tripotassium EDTA (2-8 ºC - Refrigerate)

Therapeutic R.:

100.00 - 500.00 µg/L * 0.003693 = µmol/L

15797

MALDI-TOF IDENTIFICATION

Method:

Mass Spectrometry (MALDI-TOF)

Mounting:

Delivery period:1

Reference V.:

Not available

15798

MICROBIAN METABOLITES, URINE

Method:

Gas Chromatography - Mass spectrometry.

Mounting:

Delivery period:23

Sample:

20 mL Urine (2-8 ºC - Refrigerate)

Reference V.:

Reported for each case

15851

MYCOPLASMA GENITALUM DNA, GENITAL SMEAR

Method:

Multiplex PCR-Real Time.

Mounting:

Delivery period:4

Sample:

1 Sample/s Smear (2-8 ºC - Refrigerate)

Reference V.:

Negative

15897

METHYLCROTONYLGLICINURY TYPE II (MCCC2 GENE), AMNIOTIC FLUID

Method:

PCR-Sequencing.

Mounting:

Delivery period:25

Sample:

10 mL Amniotic fluid (12-20 ºC - Ambient Temp.)

Request form:

Clinical information required.

Sample extraction:

It´s necessary to send 5 mL maternal EDTA blood in order to discard a maternal contamination.

Reference V.:

Reported for each case

15918

MYCOBACTERIUM TUBERCULOSIS, ASCYTIC LIQUID

Method:

Real Time PCR.

Mounting:

Delivery period:11

Sample:

1 mL Ascites fluid (2-8 ºC - Refrigerate)

Reference V.:

Not available

15919

MYCOBACTERIUM TUBERCULOSIS ADN, LCR

Method:

Real Time PCR.

Mounting:

Delivery period:11

Sample:

1 mL Cerebrospinal liquid (2-8 ºC - Refrigerate)

Reference V.:

Negative

16103

METHOTREXATE, SERUM

Method:

Homogeneous enzyme immunoassay (EMIT).

Mounting:

Delivery period:1

Sample:

1 mL Serum (2-8 ºC - Refrigerate)
Alt. 1 mL Plasma Heparin lithium (2-8 ºC - Refrigerate)

Toxic C.:

1-2 weeks after high-dose therapy > 0.02 umol/L
24 h after high-dose therapy > 5.00 umol/L
48 h after high-dose therapy > 0.50 umol/L
72 h after high-dose therapy > 0.05 umol/L

16204

MICRODELETION SYNDROMES (MLPA), BLOOD

Method:

MLPA (Multiplex Ligation-dependent Probe Amplification).

Mounting:

Delivery period:35

Sample:

5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)

Request form:

Clinical information required.

Sample extraction:

Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.

Reference V.:

Reported for each case

16260

MUSCULAR DYSTROPHY MEROSIN-DEFICIENT (LAMA2 GENE: MLPA), BLOOD

Method:

MLPA (Multiplex Ligation-dependent Probe Amplification).

Mounting:

Delivery period:35

Sample:

5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)

Request form:

Clinical information required.

Sample extraction:

Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.

Reference V.:

Reported for each case

16277

MAYARO VIRUS RNA, PLASMA

Method:

Real Time RT-PCR.

Mounting:

Delivery period:14

Sample:

1 mL Plasma Tripotassium EDTA (-8 ºC - Freeze)

Reference V.:

Negative

16280

MALONIC ACIDURIA (MLYCD GENE: NGS), BLOOD

Method:

Next Generation Sequencing (NGS).

Mounting:

Delivery period:45

Sample:

10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)

Request form:

Clinical information required.

Sample extraction:

Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.

Reference V.:

Reported for each case

16288

MUCKLE-WELLS SYNDROME (NLRP3 GENE: NGS), BLOOD

Method:

Next Generation Sequencing (NGS).

Mounting:

Delivery period:45

Sample:

10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)

Request form:

Clinical information required.

Sample extraction:

Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.

Reference V.:

Reported for each case

16306

MENTAL RETARDATION SYNDROMIC X-LINKED (ATP6AP2 GENE: NGS), BLOOD

Method:

Next Generation Sequencing (NGS).

Mounting:

Delivery period:45

Sample:

10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)

Request form:

Clinical information required.

Sample extraction:

Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.

Reference V.:

Reported for each case

16318

MULTIPLE ENDROCRINE NEOPLASIA (2 GENES PANEL: NGS), BLOOD

Method:

Next Generation Sequencing (NGS).

Mounting:

Delivery period:45

Sample:

5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)

Request form:

Clinical information required.

Sample extraction:

Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.

Reference V.:

Reported for each case

16433

MEDULLARY CYSTIC KIDNEY DISEASE 2 (UMOD GENE: NGS), BLOOD

Method:

Next Generation Sequencing (NGS).

Mounting:

Delivery period:45

Sample:

10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)

Request form:

Clinical information required.

Sample extraction:

Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.

Reference V.:

Reported for each case

16434

MEDULLARY CYSTIC KIDNEY DISEASE 2 (UMOD GENE: KNOWN MUTATION), BLOOD

Method:

PCR-Sequencing.

Mounting:

Delivery period:35

Sample:

5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)

Request form:

Clinical information required.

Sample extraction:

Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.

Reference V.:

Reported for each case

16580

MAPLE SYRUP URINE DISEASE TYPE 1B (BCKDHB GENE), CHORIONIC VILLI

Method:

PCR-Sequencing.

Mounting:

Delivery period:25

Sample:

0.02 g Corial villus (12-20 ºC - Ambient Temp.)

Request form:

Clinical information required.

Sample extraction:

It´s necessary to send 5 mL maternal EDTA blood in order to discard a maternal contamination.

Reference V.:

Reported for each case

16615

MAST CELL DISEASE (C-KIT GENE: EXON 17), BONE MARROW

Method:

PCR-Sequencing.

Mounting:

Delivery period:35

Sample:

2 mL Bone marrow Tripotassium EDTA (2-8 ºC - Refrigerate)

Request form:

Clinical information required.

Sample extraction:

Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.

Reference V.:

Reported for each case

16634

MYELOPROLIFERATIVE CHRONIC SYNDROME (EXON 9 CALR GENE), BONE MARROW

Method:

PCR-Sequencing.

Mounting:

Delivery period:25

Sample:

2 mL Bone marrow Tripotassium EDTA (2-8 ºC - Refrigerate)

Request form:

Clinical information required.

Sample extraction:

Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.

Reference V.:

Reported for each case

16680

MOG NEURONAL ANTIBODIES, SERUM

Method:

Indirect Immunofluorescense.

Mounting:

Delivery period:11

Sample:

1 mL Serum (2-8 ºC - Refrigerate)

Interpretation:

Positive: >= to 1/10 Título

Negative:

< 1/10 Título

16681

MOG NEURONAL ANTIBODIES, CSF

Method:

Indirect Immunofluorescense.

Mounting:

Delivery period:11

Sample:

1 mL Cerebrospinal liquid (2-8 ºC - Refrigerate)

Interpretation:

Positive: >= to 1/10 Título

Negative:

< 1/10 Título

16729

MYOCLONIC-ASTATIC EPILEPSY (5 GENES PANEL: NGS), BLOOD

Method:

Next Generation Sequencing (NGS).

Mounting:

Delivery period:45

Sample:

10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)

Request form:

Clinical information required.

Sample extraction:

Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.

Reference V.:

Reported for each case

16757

MIOCLONIC-ATONIC EPILEPSY (SLC6A1 GENE: NGS), BLOOD

Method:

Next Generation Sequencing (NGS).

Mounting:

Delivery period:45

Sample:

10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)

Request form:

Clinical information required.

Sample extraction:

Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.

Reference V.:

Reported for each case

16767

MYOFIBRILLAR MYOPATHY 3 (MYOT GENE: KNOWN MUTATION), BLOOD

Method:

PCR-Sequencing.

Mounting:

Delivery period:35

Sample:

5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)

Request form:

Clinical information required.

Sample extraction:

Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.

Reference V.:

Reported for each case

16769

MYELOID NEOPLASIA AND ACUTE LEUKEMIAS (MUTATIONS PANEL NGS), BLOOD

Method:

Next Generation Sequencing (NGS).

Mounting:

Delivery period:13

Sample:

5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)

Request form:

Clinical information required.

Sample extraction:

Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.

Reference V.:

Reported for each case

16777

MUMPS VIRUS RNA,SALIVA

Method:

RT-PCR.

Mounting:

Delivery period:8

Sample:

1 Smear Buccal smear. (-8 ºC - Freeze)

Reference V.:

Negative

16791

MARFAN SYNDROME (FBN1 GENE), CHORIONIC VILLI

Method:

PCR-Sequencing.

Mounting:

Delivery period:25

Sample:

0.01 g Corial villus RPMI media (12-20 ºC - Ambient Temp.)

Request form:

Clinical information required.

Sample extraction:

It´s necessary to send 5 mL maternal EDTA blood in order to discard a maternal contamination.

Reference V.:

Reported for each case

16818

MUSCULAR DYSTROPHY (38 GENES PANEL: NGS), BLOOD

Method:

Next Generation Sequencing (NGS).

Mounting:

Delivery period:45

Sample:

10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)

Request form:

Clinical information required.

Sample extraction:

Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.

Reference V.:

Reported for each case

16819

MITOCHONDRIAL DNA 2 DEPLETION SYNDROME (TK2 GENE: NGS), BLOOD

Method:

Next Generation Sequencing (NGS).

Mounting:

Delivery period:45

Sample:

10 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)

Request form:

Clinical information required.

Sample extraction:

Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.

Reference V.:

Reported for each case

16854

Mi2-ALPHA ANTIBODIES, SERUM

Method:

Immunoblot.

Mounting:

Delivery period:5

Sample:

1 mL Serum (2-8 ºC - Refrigerate)
Alt. 1 mL Plasma Sodium Citrate (2-8 ºC - Refrigerate)
Alt. 1 mL Plasma Tripotassium EDTA (2-8 ºC - Refrigerate)
Alt. 1 mL Plasma Heparin lithium (2-8 ºC - Refrigerate)

Reference V.:

Negative

16855

Mi2-BETA ANTIBODIES, SERUM

Method:

Immunoblot.

Mounting:

Delivery period:5

Sample:

1 mL Serum (2-8 ºC - Refrigerate)
Alt. 1 mL Plasma Sodium Citrate (2-8 ºC - Refrigerate)
Alt. 1 mL Plasma Tripotassium EDTA (2-8 ºC - Refrigerate)
Alt. 1 mL Plasma Heparin lithium (2-8 ºC - Refrigerate)

Reference V.:

Negative

16889

MYCOPLASMA GENITALUM DNA, URINE

Method:

Multiplex PCR-Real Time.

Mounting:

Delivery period:4

Sample:

10 mL Urine (2-8 ºC - Refrigerate)

Reference V.:

Negative

16890

MYCOPLASMA HOMINIS DNA, URINE

Method:

Multiplex PCR-Real Time.

Mounting:

Delivery period:4

Sample:

10 mL Urine (2-8 ºC - Refrigerate)

Reference V.:

Negative

16902

MYELODYSPLASTIC SYNDROME (SF3B1 GENE: NGS), BLOOD

Method:

Next Generation Sequencing (NGS).

Mounting:

Delivery period:25

Sample:

5 mL Total blood Tripotassium EDTA (2-8 ºC - Refrigerate)

Request form:

Clinical information required.

Sample extraction:

Do not send specimens with heparin, hemolyzed or lipemic, because they inhibit the polymerase of PCR.

Reference V.:

Reported for each case

Solutions on special tests

Catalog